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MEDICAL MALPRACTICE AND
MANAGED CARE ORGANIZATIONS:
THE IMPLIED WARRANTY OF QUALITY
WILLIAM S. BREWBAKER III*
I
INTRODUCTION
With the advent of managed health care, medical malpractice law is once
again seizing the public’s attention. The prime targets in the new malpractice
litigation are often not only doctors, but also the corporations that pay them.
Generically referred to as managed care organizations (“MCOs”), these entities include health maintenance organizations (“HMOs”), preferred provider
organizations (“PPOs”) and other vertically and horizontally integrated provider networks. MCOs are unlike traditional indemnity insurers in that they
sell prepaid medical services rather than financial coverage, limit their members’ choice of providers, make independent medical determinations about
what care is worth paying for, employ payment mechanisms that induce providers to economize on treatment, or engage in some combination of the above.
As MCOs have become more aggressive in their cost-containment efforts, public apprehension about market-based medical care has increased. When medical errors occur, members of managed care plans are inclined to blame not only
the doctor but the MCO as well.
Blaming an MCO for deficient medical care is one thing; getting a judgment
against it is another. Courts currently employ general principles of vicarious
liability in deciding whether an MCO can be held accountable for a physician’s
malpractice. Under these rules, an MCO’s liability is dependent upon proof of
either the MCO’s direct negligence or the existence of an actual or apparent
master-servant (that is, control) relationship between the MCO and the physician. Because there is a strong presumption in American law that physicians
are independent contractors, MCOs that do not employ their physicians often
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enjoy virtual immunity from liability for provider malpractice.1
As MCOs have come to exert more influence in the provision of medical
services, their lack of accountability for provider negligence has become untenable. It has been challenged as a matter of fairness (many MCO practices seem
likely to contribute to medical injury), as a matter of safety (MCOs are in a
good position to take positive steps to prevent medical injuries), and as a matter of efficient compensation for injury (MCOs are already in the insurance
business and are good risk-spreaders). There is also palpable judicial unease
over the state of the law; courts appear to be pushing vicarious liability principles to the limit in order to generate appropriate levels of accountability. The
Clinton proposal to reform the nation’s health care system initially included
provisions that would have made MCOs solely liable for their physicians’ malpractice.2 In addition, several states either have recently enacted or are considering legislation that would expand MCO liability for physicians’ negligence as
well as for benefit determination decisions.3
I will argue that courts should impose a tort-based implied warranty of
quality on MCOs (defined as firms that are in the business of selling, or arranging for the sale of, medical services). Under the warranty, MCOs would be
liable for selling physician services that are negligently rendered, that is, for
their physicians’ malpractice. Grounding MCO malpractice liability in a tortbased implied warranty theory will no doubt strike many readers as a novel extension of tort law; this article’s primary contribution is to explain that this
seemingly novel theory is in fact strongly rooted in, and consistent with, established common law principles. The positive legal argument I will make is supported along the way by the normative arguments in favor of MCO liability already noted, as well as by additional policy considerations.
The argument begins with the observation that caveat emptor has never
1. MCOs do not typically enjoy de jure immunity from malpractice liability. In a few states,
HMOs enjoy de jure immunity conferred by statute or based on the “corporate practice of medicine”
doctrine. For a discussion of these immunities, see William S. Brewbaker III, Managed Care Liability,
in HEALTH CARE CORPORATE LAW: MANAGED CARE, 6-1, 6-30 to 6-32 (Mark A. Hall & William S.
Brewbaker III eds., 1996).
2. See Kenneth S. Abraham & Paul C. Weiler, Enterprise Medical Liability and the Evolution of
the American Health Care System, 108 HARV. L. REV. 381, 382-84 (1994) [hereinafter Enterprise
Medical Liability] (describing the demise of enterprise liability provisions in the Clinton Plan); Sharon
M. Glenn, Comment, Tort Liability of Integrated Health Care Delivery Systems: Beyond Enterprise Liability, 29 WAKE FOREST L. REV. 305, 309-11 (1994) (same).
3. Legislation recently enacted in Texas and Missouri would end immunities currently enjoyed by
HMOs. Texas courts had previously recognized a “corporate practice of medicine” defense to HMO
liability claims. See, e.g., Williams v. Good Health Plus, 743 S.W.2d 373, 378 (Tex. App. 1988). Under
the new legislation, HMOs can be liable for failure “to exercise ordinary care when making health care
treatment decisions” and “for harm to an … enrollee proximately caused by the health care treatment
decisions made by its (1) employees, (2) agents, (3) ostensible agents, or (4) representatives who are
acting on its behalf and over whom it has the right to exercise influence or control or has actually exercised influence or control which result in the failure to exercise ordinary care.” TEX. CIV. PRAC. &
REM. CODE ANN. § 88.002 (West 1997). A recently enacted Missouri statute removes immunity previously conferred on HMOs pursuant to that state’s HMO Act. See H.R. 335, 89th Gen. Assembly
(Mo. 1997) (enacted June 25, 1997). Other states are considering similar legislation. See Leigh Page,
Texas Eyes Measure to Extend Liability to Managed Care, AM. MED. NEWS, Apr. 14, 1997, at 4.
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governed the sale of professional or trade services. At least since Blackstone
wrote, most professionals and other service providers were held to an implied
contractual undertaking to render their services with “integrity, diligence, and
4
skill.” Significantly, when medical services were being sold, the physicianseller’s obligation to the patient (as embodied in the law of medical malpractice) strongly resembled the implicit contractual undertakings the law imposed
on other professionals. Nevertheless, the physician’s obligation originated in
tort rather than contract, reflecting judicial solicitude for the patient’s interest
in bodily integrity. In other words, for the last 200-plus years, sellers of medical
5
services have owed their patients a tort-based implied warranty of quality. As
I frame the issue of MCO liability, the question is simple: Should the implied
warranty that already governs physician-sellers of medical services also apply to
MCOs? I will argue from both a positive and a normative perspective that it
should.
The argument might end there, were it not for a well-known line of cases
commonly understood to hold that products liability principles do not apply to
6
the sellers of services, including medical services. Though developed in an entirely different context, the principles of products liability law bear a sufficient
resemblance to the implied warranty of quality proposed here that it is necessary to distinguish this line of cases (which I shall refer to as “products versus
services” cases). An historical examination of the gradual evolution of products liability law will reveal that the “products versus services” cases are not
opposed to the implied warranty. Rather, they are best understood as judicial
rejections of plaintiffs’ attempts to replace the negligence standard of malprac4. 3 WILLIAM BLACKSTONE, COMMENTARIES ON THE LAWS OF ENGLAND 163 (1825).
5. See infra Part II.
6. See RESTATEMENT (THIRD) OF THE LAW OF TORTS: PRODUCTS LIABILITY § 19(b) (Proposed
Final Draft 1997) (“Services, even when provided commercially, are not products.”); id. cmt. f
(“Courts are unanimous in refusing to categorize commercially provided services as products for the
purposes of strict products liability in tort.”); see, e.g., Stewart Warner Corp. v. Burns Intl Security
Serv., Inc., 343 F. Supp 953 (N.D. Ill. 1972) (security services); Pepsi Cola Bottling Co. v. Superior
Burner Serv. Co., 427 P.2d 833 (Alaska 1967) (repair services); Lucas v. Hamm, 364 P.2d 685 (Cal.
1961) (legal services); Allied Properties v. John Blume & Assocs., 102 Cal. Rptr. 259 (Cal. Ct. App.
1972) (engineering services); Micciche v. Eastern Elevator Co., 645 A.2d 278 (Pa. Super. Ct. 1994)
(elevator maintenance); Hannis v. Ashland State Gen. Hosp., 544 A.2d 574 (Pa. Commw. Ct. 1989)
(medical services); Hoven v. Kelble, 256 N.W.2d 379 (Wis. 1977) (medical services). But see Johnson
v. Sears, Roebuck & Co., 355 F. Supp. 1065 (E.D. Wis. 1973) (allowing strict product liability action
against hospital for mechanical and administrative services); Broyles v. Brown Engineering Co., 151
So.2d 767 (Ala. 1963) (engineering services). Courts are divided in their treatment of so-called
“hybrid” sales/services transactions. The most recent Restatement divides such transactions into two
categories: “[i]n the first, the product component is consumed in the course of providing the service, as
when a hair dye is used in treating a customer’s hair in a salon. . . . [T]he transaction is ordinarily
treated as a sale of the material.” R ESTATEMENT, supra, § 20 cmt. d. The second category involves
cases where “the product component … is not consumed or permanently transferred to the customer—
as when defective scissors are used in the hair salon.” Id. Such transactions “ordinarily [are] treated
as … not involving the sale of the product to the customer.” Id. Compare Newmark v. Gimbels, Inc.,
258 A.2d 697 (N.J. 1969) (holding a beauty parlor liable for injuries caused by chemicals applied to patron’s hair) with Coleman v. Charlesworth, 608 N.E.2d 464 (Ill. App. Ct. 1992) (holding that balloon
ride is a service). According to the Restatement, a “strong majority” of jurisdictions hold that hospitals are not sellers “of the products they supply in connection with the provision of medical care, regardless of the circumstances.” RESTATEMENT, supra, § 20 cmt d.
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tice liability with a more demanding liability standard modeled after section
402A of the Restatement (Second) of Torts. Unlike the strict liability standard
rejected in the “products versus services” cases, the implied warranty advocated here would not raise the legal benchmark used to measure the quality of
medical services.
After concluding that the “products versus services” cases do not preclude
the implied warranty as a matter of positive law, I argue that products liability
precedents actually provide support for it. In addition to the strict liability
principle rejected in the “products versus services” cases, products liability law
also includes cases embodying what will be referred to as the “seller accountability” principle. In addition to tracing the origins of the implied warranty to
the traditional malpractice obligations of physicians and distinguishing the
“products versus services” cases, Part II of this article invokes the seller accountability theme to support the imposition of an implied warranty against
MCOs. Part III provides a complementary policy analysis, focusing on traditional concerns about fairness, efficiency, compensation, and deterrence as well
as on the suitability of the implied warranty doctrine to resolution of MCO liability claims. Part IV outlines the contours of the implied warranty in greater
detail and makes specific suggestions for applying implied warranty doctrine in
liability litigation against MCOs. The article concludes with a brief reflection
on the usefulness of implied warranties for resolving pressing issues in managed
care liability litigation.
This article focuses on the implied warranty of quality as a mechanism for
dealing with an important, though relatively narrow, problem: MCOs’ liability
for the negligent acts and omissions of affiliated providers. However, the warranty might well produce other even more significant benefits were it to become the starting point in medical liability litigation. Specifically, it provides a
potential avenue for bringing ERISA preemption jurisprudence in line with the
realities of managed care. ERISA has been held to preempt actions against
employer-sponsored health plans, including MCOs, where the action is a “claim
for benefits” or alleges direct negligence on the part of the MCO, but not
7
where the lawsuit is based on vicarious liability for physician negligence. The
ERISA cases thus assume a bright-line division of responsibility between
health plans and providers for the care patients receive—physicians “treat” and
plans “pay.”
One of the themes of this article will be that this conception of medical
7. In the leading case on this point, the Fifth Circuit acknowledged that utilization reviewers
make medical determinations much in the way attending physicians do. See Corcoran v. United
Health Care, 965 F.2d 1321 (5th Cir. 1992). However, the court held that because those determinations are made in order to decide whether an ERISA plan member is entitled to benefits, the plaintiffs
negligence claim amounted to an allegation that “a tort [was] committed in the course of handling a
benefit determination.” Id. at 1332. As such, the claim would be preempted under ERISA. See Tolton v. American Biodyne, Inc., 48 F.3d 937 (6th Cir. 1995); Kuhl v. Lincoln Natl Health Plan, 999 F.2d
298 (8th Cir. 1993), cert. denied, 114 S.Ct. 694 (1994); Spain v. Aetna Life Ins. Co., 11 F.3d 129 (9th
Cir. 1993); Pomeroy v. Johns Hopkins Medical Servs., 868 F.Supp. 110 (D. Md. 1994); Stroker v. Rubin, 1994 WL 719694 (E.D. Pa. Dec. 22, 1994); see also Pilot Life v. Dedeaux, 481 U.S. 41 (1987)
(holding that ERISA preempts state tort claim alleging bad faith breach of ERISA plan contract).
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practice is untenable in the context of managed care. In managed care, the
provision of medical services is a joint effort of health plan and provider;
MCOs inevitably exert significant influence over the shape of the care their
8
members receive. While an examination of the interplay between ERISA preemption jurisprudence and the implied warranty is beyond the scope of this article, it is worth noting briefly that an MCO’s decision to withhold benefits
(scrutiny of which is currently preempted) would constitute a breach of the implied warranty of quality if the result of the decision were that the treatment
the patient received fell below the standard of care. Given the origins of the
9
implied warranty in the traditional law of medical malpractice, and the refusal
10
of courts to invoke ERISA to preempt medical malpractice claims, the implied warranty may well survive an ERISA preemption challenge, even when
the plaintiff’s case could be recharacterized as a “claim for benefits” that would
have been preempted under current ERISA standards.
II
MEDICAL MALPRACTICE LAW THROUGH A WARRANTY LENS
A. Malpractice Law and Health Care Delivery
At least since Blackstone’s time, courts have imposed what amounts to a
tort-based implied warranty of quality on sellers of medical services.11 The
common law required “every one who undertakes any office, employment,
12
trust, or duty … to perform it with integrity, diligence, and skill.” Like other
service providers, physicians could be held liable for “neglect or unskillful
13
management.” However, in contrast to the obligations of lawyers, tailors,
innkeepers and others, the physician’s duty of care arose not primarily from
implied contractual obligations but rather from the patient’s interest in bodily
integrity. The Commentaries described “mala praxis” as a “great misdemeanor
14
and offense at common law” and classified it with other “injuries which affect
15
the personal security of individuals,” including threats, assaults, battery, mayhem and defamation. The implied warranty of quality as embodied in physi8. See infra Part II.C.
9. See infra Part II.A.
10. Although a few lower courts have held that ERISA preempts malpractice claims against
MCOs in connection with service provided through an ERISA plan, see, e.g., Pomeroy v. Johns Hopkins Med. Services, Inc., 868 F. Supp 110 (D. Md. 1994), there appears to be a trend emerging among
the U.S. Circuit Courts of Appeal to the contrary. See, e.g., Pacificare of Oklahoma, Inc. v. Burrage,
59 F.3d 151 (10th Cir. 1995); Rice v. Panchal, 65 F.3d 637 (7th Cir. 1995); Dukes v. U.S. Healthcare,
Inc., 57 F.3d 350 (3d Cir. 1995). Assuming this trend continues, the implied warranty of quality advocated in this article should withstand a claim of ERISA preemption.
11. See Michael M. Greenfield, Consumer Protection in Service TransactionsImplied Warranties
and Strict Liability in Tort, 1974 UTAH L. REV. 661, 663-68 & nn. 20-29 (characterizing negligence as a
form of implied warranty and collecting cases).
12. BLACKSTONE, supra note 4, at 163.
13. Id. at 122.
14. Id.
15. Id. at 119.
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cians’ malpractice obligations has thus traditionally been a hybrid of tort obligations and implied contractual undertaking.
Both the contract and tort aspects of the malpractice warranty strongly suggest that it should apply to MCOs. First, as a contractual warranty, it is implied
as an incident to the sale of services. As sellers, physicians have long been obligated to stand behind their services and are subject to liability for services
performed without due diligence and skill. MCOs likewise have the contractual obligation to deliver value in exchange for their patrons’ money. Second,
because the implied warranty of quality is grounded in tort law’s special solicitude for bodily integrity, courts should be hesitant to allow MCOs to avoid its
reach. Like physicians, MCOs trade in medical services, the skillful and diligent delivery of which is crucial to patients’ personal bodily security. This suggests not only that courts should be skeptical of contractual attempts to evade
16
the warranty, but also that they should be slow to absolve MCO-sellers of responsibility for the quality of the services they sell.
If physicians’ obligations under the law of medical malpractice can be aptly
characterized as an implied warranty that ought to attach to any seller of medical services, one might well ask why courts have not yet seized on this theory to
17
impose liability on MCOs. The most important reason implied warranty theories have not taken hold is probably that, until recently, only physicians sold
medical services.
In this respect, the evolution of the medical profession has been different
from that of other occupations. Other service providers—for example, butchers, tailors, and mechanics—were absorbed into corporate structures long before physicians began to be. While corporations sold the goods and services
these workers produced, physicians continued to practice solo or in small
groups.18 This was partly the result of policies implemented by organized medi16. Courts generally refuse to enforce waivers of malpractice liability. See, e.g. Tunkl v. Regents
of the University of California, 383 P.2d 441 (Cal. 1963) (holding that release executed by indigent patient in consideration of free medical care held unenforceable); Emory Univ. v. Porubianski, 282
S.E.2d 903 (Ga. 1981) (holding that release executed in consideration of low-cost care held unenforceable). See also RESTATEMENT (THIRD) OF TORTS, supra note 6, § 14 (“Disclaimers and limitations of
remedies by product sellers or other distributors, waivers by product purchasers, and other similar contractual exculpations, oral or written, do not bar or reduce otherwise valid products liability claims
against sellers or other distributors of new products for harm to persons.”) Notwithstanding the tort
origins of the implied warranty, courts would be justified in permitting reasonable contractual modifications in appropriate cases. Cf. id. cmt. d (“[Section 14] does not address whether consumers, especially when represented by informed and economically powerful consumer groups or intermediaries,
with full information and sufficient bargaining power, may contract with product sellers to accept curtailment of liability for concomitant benefits . . . . When such contracts are accompanied by alternative
nontort remedies that serve as an adequate quid pro quo for reducing or eliminating rights to recover
in tort, arguments may support giving effect to such agreements. Such contractual arrangements raise
policy questions different from those raised by this Section and require careful considerations by the
courts.”) See also CLARK C. HAVIGHURST, HEALTH CARE CHOICES: PRIVATE CONTRACTS AS
INSTRUMENTS OF HEALTH REFORM 265-302 (1995) (arguing that some consumers might rationally
prefer to alter otherwise applicable malpractice rules and suggesting possible modifications).
17. In fact, the outcomes of MCO liability cases are often more consistent with an implied warranty theory than with the legal theories that courts purport to apply. See infra Part IV.B.
18. See PAUL STARR, THE SOCIAL TRANSFORMATION OF AMERICAN MEDICINE 25 (1982); 2
THE AMERICAN LAW INSTITUTE, REPORTER’S STUDY: ENTERPRISE RESPONSIBILITY FOR
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cine that were aimed at preserving physicians’ control over the conditions of
their work,19 and partly the result of the fact that there were no appreciable
economies of scale in medical practice.20
The ability of physicians to resist corporate control for the better part of
this century allowed the law of medical malpractice to remain fundamentally
unchanged—even as industrial developments sparked a revolution in other legal frameworks. For example, as buyers in commercial transactions increasingly began dealing directly with distant manufacturers, courts began imposing
21
implied warranties that protected them against economic loss. Later, concerns over the accountability of distant sellers to consumers led to the strict
products liability regime embodied in section 402A of the Restatement
(Second) of Torts. Doctors, however, were already subject to the tort-based
implied warranty embodied in the sale of medical services. As long as medical
22
care continued to be sold on a person-to-person basis, there was no need to

PERSONAL INJURY 115 (Paul C. Weiler ed., 1991) (describing the American medical system as “one of
the last outposts of the independent entrepreneur”).
19. See STARR, supra note 18, at 229-31 (noting five structural changes affecting the distribution of
power in American medicine: (1) the growth of specialization, which “encouraged former rivals to put
aside their differences and work together in behalf of … common political objectives,” (2) the professions securing control over medical licensing and therefore of labor markets for medical services; (3)
the avoidance of “commercialism” in medicine, which allowed physicians freely to avail themselves of
capital supplied by others; (4) the “elimination of countervailing power” in medical care by prohibitions on participation by the state, corporations, or voluntary associations in the market for medical
services; and (5) “the establishment of specific spheres of professional authority,” which prevented
functional integration that might have challenged professional prerogatives.) See also Mark A. Hall,
Institutional Control of Physician Behavior: Legal Barriers to Health Care Cost Containment, 137 U.
PA. L. REV. 431, 434 (1988) (arguing that “cost containment programs are fundamentally at odds with
the professional libertarian values of physician autonomy that are embedded in the law to preserve the
practitioners independence from the institution”); Clark C. Havighurst, Professional Restraints on Innovation in Health Care Financing, 1978 DUKE L.J. 303 (cataloguing mechanisms whereby organized
medicine restrained financing innovations that threatened physician interests).
20. See STARR, supra note 18, at 19, 26-27, 206, 217, 218, 220.
21. See generally K.N. Llewellyn, Of Warranty of Quality, and Society: II, 37 COLUM. L. REV. 341,
349-53 (1937).
22. For the better part of this century, it would have been highly implausible to characterize most
hospitals as “sellers” of medical services provided by staff physicians. Even when medical services
were provided in the hospital, physicians’ success in shielding themselves from any accountability to
hospital administrators led to a “physicians workshop” or “aircraft carrier” model of hospital administration, remnants of which still persist. This model presupposes a fine line between “medical services,” for which physicians are responsible and the hospital is not, and “administrative services,” for
which the reverse is true. 1 BARRY R. FURROW ET AL., HEALTH LAW, 449 (1995); see also Albain v.
Flower Hosp., 553 N.E.2d 1038, 1046 (Ohio 1990) (explaining that a physician’s negligence does not
automatically impose liability on a hospital). The model affirmatively avoids any integrating of physicians’ services with those of the hospital. See Jeffrey Harris, The Internal Organization of Hospitals:
Some Economic Implications, 8 BELL J. ECON. 467, 470-72 (1977) (describing organizational model of
hospital as “two firms loosely connected by a complex set of nonmarket relations”). It also ensured
physician supremacy, since under a regime of cost-based reimbursement and indemnity insurance,
physicians could use their patients’ purchasing power as leverage against the hospital. Indeed, prior to
the demise of hospitals’ charitable immunity, physician control within the hospital even led courts to
impose liability on physicians for nurses’ (i.e., hospital employees’) torts in some circumstances. See 1
FURROW ET AL., supra, § 7-2(b) (1995) (describing the “Captain of the Ship” and “borrowed servant”
doctrines). See also Truhitte v. French Hosp., 180 Cal. Rptr. 152, 160 (Cal. Ct. App. 1982) (tracing the
origin of the Captain of the Ship doctrine to “the need to assure plaintiffs a source of recovery for
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discard the tort-based “malpractice” vocabulary of medical liability.
An additional reason courts have not used implied warranty theory to analyze medical liability claims against MCOs is the association of “implied warranty” terminology with the law of products liability. As mentioned earlier, a
well-known line of cases is commonly understood to hold that products liability
principles do not apply to the sellers of services, including medical services.
Because the implied warranty of quality proposed here traces its origins to the
traditional obligations of sellers of medical services embodied in malpractice
law and not to principles of products liability, these cases are arguably irrelevant. Even so, there is a strong association in the legal mind between implied
warranties and principles of products liability generally. The next section argues that, properly understood, the “products versus services” cases did not
reject implied warranty as a theory of MCO liability, but were merely a repudiation of proposals to replace the negligence-based standard of malpractice
law with more demanding liability standards modeled after section 402A of the
Restatement (Second) of Torts.
B. The Origin of the “Products Versus Services” Distinction
While it is easy to find judicial statements to the effect that products liabil23
ity principles do not apply to the sale of services, those statements are ultimately misleading. Products liability is a complex agglomeration of tort and
contracts doctrines, including strict liability, negligence, vicarious liability, and
express and implied warranty. As a result, it is easy to paint with too broad a
24
brush in describing products liability rules. This section reviews gradual developments in products liability law and product markets and contrasts them
with the comparatively stable (until recently) world of medical practice and
medical liability. In so doing, it argues that the “products versus services” cases
have been largely misunderstood. Those cases clearly did turn away attempts

malpractice at a time when many hospitals enjoyed charitable immunity”). Although the importance
of the Captain of the Ship doctrine has diminished with the abrogation of charitable immunity and the
expansion of hospital liability generally, see Stephen H. Price, The Sinking of the “Captain of the Ship”:
Reexamining the Vicarious Liability of an Operating Surgeon for the Negligence of Assisting Hospital
Personnel, 10 J. LEG. MED. 323 (1989), the doctrine can be seen as an expression of “seller accountability” occurring outside the confines of products liability law. See infra Part II.C. (discussing principle of seller accountability). The analogy is particularly apt given the de facto control physicians have
exercised over hospitals for most of this century. See generally STARR, supra note 28, at 162-169; Robert C. Clark, Does the Nonprofit Form Fit the Hospital Industry?, 93 HARV. L. REV. 1416 (1980); Mark
V. Pauly & Michael Redisch, The Not-for-Profit Hospital as a Physicians Cooperative, 63 AM. ECON.
REV. 87 (1973). Hospital administrators today enjoy considerably more power over physicians than
was previously the case. INSTITUTE OF MEDICINE, FOR-PROFIT ENTERPRISE IN HEALTH CARE 172
(1986) (cataloguing reasons for increased power). Not surprisingly, as hospitals have (correctly) come
to be viewed as more involved in the delivery of “medical” services, their liability has increased. See
generally 1 FURROW ET AL., §§ 7-2 to 7-4 (1995) (describing evolution of tort obligations of hospitals).
23. See supra note 6.
24. The most common example of this tendency is the frequent association of products liability
law with strict liability, which, in fact, applies only to manufacturing defects but not to design defects
or failures to warn.
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to use products liability precedent to displace the negligence-based malpractice
standard. They need not, however, be read as forbidding the application of
products liability concepts to consumer transactions with MCOs or as requiring
that caveat emptor become the governing principle in MCO-consumer relationships. Such readings completely ignore an important principle of products liability law—that commercial sellers incur tort-based obligations to protect the
public from personal injury.
As already noted, common law courts during Blackstone’s era did not hesitate to employ tort and implied contract principles to require physicians and
other sellers of services to render those services with diligence and skill. By
contrast, probably because a purchaser could inspect goods before paying for
them, caveat emptor initially governed the sale of products.25 The law implied a
warranty that the seller had title to the goods he sold, but held the seller accountable with respect to the quality of the goods only in a few exceptional
cases—where the seller had given an express warranty, where the goods were
“provisions” (in which case they had to be “wholesome”), or where the seller
knowingly misrepresented the goods or attempted to hide their defects.26
Needless to say, caveat emptor did not survive. By the mid-nineteenth century, courts had begun implying warranties of merchantability in connection
with the sale of goods. However, these warranties protected buyers only
against intangible economic loss.27 Purchasers suffering personal injury or destruction of property could recover only in tort. Furthermore, under the rule of
28
Winterbottom v. Wright, manufacturers of defective products could be sued in
tort only by a direct purchaser. Unless a plaintiff could show that his direct
seller were at fault (either as manufacturer or by failing to inspect the product
adequately), he had no remedy for personal injury.
Winterbottom eventually went the way of caveat emptor. Support for the
29
Winterbottom holding had been gradually eroding for some time when the
30
case of MacPherson v. Buick Motor Co. was decided. In MacPherson, Judge
Cardozo held that
[i]f the nature of a thing is such that it is reasonably certain to place life and limb at
25. See Jones v. Just, L.R. 3 Q.B. 197 (1868); 3 BLACKSTONE, supra note 4, at 165; Jon Chait,
Note, Continuing the Common Law Response to the New Industrial State: The Extension of Enterprise
Liability to Consumer Services, 22 UCLA L. REV. 401, 404-07 (1974).
26. 3 BLACKSTONE, supra note 4, at 164-65; KEETON ET. AL., PROSSER AND KEETON ON TORTS §
95A, at 679 (5th ed. 1984).
27. See KEETON ET AL., supra note 26, § 95A, at 680-81.
28. 152 Eng. Rep. 402 (1842).
29. The most important exception to the Winterbottom rule dealt with inherently dangerous products. KEETON ET. AL., supra note 26, § 96, at 682. Other exceptions included negligence in connection
with a sale, when the conduct of the vendor was “imminently dangerous,” Huset v. J. I. Case Threshing
Co., 120 F. 865, 870 (8th Cir. 1903), and injury to a non-party to a contract when the injury resulted
from an “invitation” issued by the defendant, id. at 870-71. See also, Bohlen, Liability of Manufacturers to Persons Other than Their Immediate Vendees, 45 L.Q. REV. 343, 361-62 (1929). (“[MacPherson]
has had a pronounced effect in stimulating the already existing tendency to extend the previously recognized exceptions . . . [s]o widely . . . that in many American jurisdictions little or nothing is left of the
immunity.”).
30. 111 N.E. 1050 (N.Y. 1916).
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peril when negligently made, … [and] there is added knowledge that the thing will be
used by persons other than the purchaser and used without new tests, then, irrespective of contract, the manufacturer of this thing of danger is under a duty to make it
31
carefully.

The manufacturer’s duty extended beyond its direct purchaser (the retailer to
whom it sold the defective product) to any foreseeable user.32
Although MacPherson is now regarded by many tort scholars as a revolutionary opinion,33 it had no contemporaneous consequences for medical malpractice law. Judge Cardozos holding that the prospect of personal injury gave
rise to tort duties on the part of manufacturers irrespective of contractual privity created no new obligations for sellers of medical services, as they were almost always sold and provided by the same person. And, as explained earlier,
common law judges had used tort principles to require physicians to provide
services with diligence and skill at least as far back as Blackstone’s time.
Only with the next products liability revolution, which gave birth to strict liability and culminated in the adoption of section 402A, did developments in
products liability law threaten to alter the medical malpractice landscape.
MacPherson had left injured consumers, assuming they could prove negligence,
with potential remedies against both manufacturers and sellers. However,
some consumers were injured by defective products notwithstanding nonnegligent manufacture or inspection in the distribution chain. Courts began
permitting implied warranty theories to support recovery for personal injuries
caused by product defects irrespective of negligence.34 Then, in Henningsen v.
35
Bloomfield Motors, Inc., an implied warranty of quality was applied against a
manufacturer that was not in privity of contract with the injured party.36 Even
so, because the implied warranty theories were derived from contract princi31. Id. at 1053.
32. See RESTATEMENT (THIRD) OF TORTS, supra note 6, § 1(“One engaged in the business of
selling or otherwise distributing products who sells or distributes a defective product is subject to liability for harm to persons or property caused by the defect.”); William L. Prosser, The Fall of the
Citadel (Strict Liability to the Consumer), 50 MINN. L. REV. 791, 817-20 (1966) (“Any user or consumer of the product … is protected by the strict liability rule.”) (collecting cases).
33. See KEETON ET AL., supra note 26, § 96 at 683 (“[The opinions] reasoning and fundamental
philosophy were clearly that the manufacturer, by placing the car upon the market, assumed a responsibility to the consumer, resting not upon the contract but upon the relation arising from his purchase,
together with the foreseeability of harm if proper care were not used.”); Bohlen, supra note 29, at 36162 (noting decision’s effect in “stimulating the . . . tendency to extend the . . . exceptions”); but see
George L. Priest, The Invention of Enterprise Liability: A Critical History of the Intellectual Foundations of Modern Tort Law, 14 J. LEGAL STUD. 461, 468 (1985) (noting limited implications of
MacPherson).
34. See generally KEETON ET AL., supra note 26, § 97, at 690-91. This development began with
cases involving food, see Ryan v. Progressive Grocery Stores, 175 N.E. 105 (N.Y. 1931) (Cardozo, J.);
Mazetti v. Armour & Co., 135 P. 633 (Wash. 1913), but was gradually extended to other products, see,
e.g., B.F. Goodrich Co. v. Hammond, 269 F.2d 501 (10th Cir. 1959); Spence v. Three Rivers Builders
& Masonry Supply, Inc., 90 N.W.2d 873 (Mich. 1958); Continental Copper & Steel Indus. v. “Red”
Cornelius, 104 So.2d 40 (Fla. Dist. Ct. App. 1958).
35. 161 A.2d 69 (N.J. 1960).
36. See Prosser, supra note 46, at 791 (“In the field of products liability, the date of the fall of the
citadel of privity can be fixed with some certainty. It was May 9, 1960, when the Supreme Court of
New Jersey announced the decision in Henningsen . . . .”).
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ples, many of the old contractual defenses resurfaced to bar recovery.37 Subsequent opinions—and ultimately section 402A of the Restatement—relied on
the prospect of personal injury and property damage to relocate strict products
liability in tort.38 The result was “a discrete area of tort law that borrows from
both negligence and warranty.”39 As the most recent Restatement explains,
modern products liability law “merges the concept of implied warranty, in
which negligence is not required, with the concept of negligence in tort, in
which contractual privity is not required.”40 The final result has been the preservation of consumer remedies not only against the manufacturer of a defective
product, but also against commercial sellers at all levels of the distribution
chain.41
In contrast with the MacPherson decision, which had no immediate implications for medical malpractice law, section 402A of the Restatement threatened
a revolution. By the 1970s, commentators42—and even an occasional judge43—
were advocating that service providers be held strictly liable for “defects.” Professor Michael Greenfield’s much cited 1974 article proposed defining a
“defective” medical service as any misdiagnosis if diagnosis were possible given
the state of the art, any failure to select the best course of treatment, or any
misapplication of the treatment selected.44 While hybrid sales/service transactions continue to vex the courts,45 judges have been virtually unanimous in rejecting the strict liability standard as applied to pure service transactions.46 The
reasons typically given include a reluctance to make the service provider
(especially the physician) a guarantor of results when “[m]edical and many
other professional services tend often to be experimental in nature, dependent
37. See KEETON ET AL., supra note 26, § 97, at 690-91. Among the defenses invoked by defendants to resist the warranty rationale for products liability were plaintiffs lack of reliance on the warranty, e.g., Davis v. Williams, 198 S.E. 357 (Ga. 1938); Kroger v. Lewelling, 145 So. 726 (Miss. 1933),
privity, see Swift & Co. v. Wells, 110 S.E.2d 203 (Va. 1959); Decker and Sons v. Capps, 164 S.W.2d 828
(Tex. 1942), notice, see Bonker v. Ingersoll Products Corp., 132 F.Supp. 5 (D. Mass. 1955); Whitfield
v. Jessup, 193 P.2d 1 (Cal. 1948), and disclaimer, see Traylor Engineering & Manufacturing Co. v. National Container Corp., 70 A.2d 9 (Del. Super. Ct. 1949); Valley Refrigeration Co. v. Lange Co., 8
N.W. 2d 294 (Wis. 1943); Rockwood & Co. v. Parrot & Co., 19 P.2d 423 (Or. 1933). See generally William L. Prosser, The Assault Upon the Citadel: Strict Liability to the Consumer, 69 YALE L. J. 1098,
1123-1131 (1960).
38. The leading case is Greenman v. Yuba Power Products, 377 P.2d 897 (Cal. 1963); RESTATEMENT (SECOND) OF THE LAW OF TORTS § 402A, cmt. m (1965) (“The liability stated in this Section does not rest upon negligence. It is strict liability . . . . The basis of liability is purely one of tort.”).
39. RESTATEMENT (THIRD) OF TORTS, supra note 6, § 1 cmt. a.
40. See id.
41. See id. § 20; see also infra Part II.
42. See Chait, supra note 25; Greenfield, supra note 11.
43. See, e.g., Johnson v. Sears, Roebuck & Co., 355 F. Supp. 1065 (E.D. Wis. 1973) (allowing strict
liability action against hospital for mechanical and administrative services); Broyles v. Brown Engineering Co., 151 So.2d 767 (Ala. 1963) (allowing strict liability against a civil engineer for faulty surveying work).
44. See Greenfield, supra note 11 (summarized in Hoven v. Kelble, 256 N.W.2d 379, 386-87 (Wis.
1977)).
45. See RESTATEMENT (THIRD) OF TORTS, supra note 6, § 20 cmt. d, (‘No unifying test had been
devised to determine whether strict liability applies in any given sales-service combination.”).
46. See generally supra note 6.
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on factors beyond the control of the professional, and devoid of certainty or assurance of results.”47 In addition, there was concern that strict liability would
raise the price of medical services, with the result that they would be harder to
obtain.48
Had the courts accepted the invitation to apply section 402A to medical
services, judicial treatment of MCO liability for physician malpractice would
have been markedly different. Instead of relying on principles of vicarious liability to determine MCO liability, the courts, following products liability principles, would have first inquired as to whether the services were defective—
perhaps using the standard suggested by Professor Greenfield. The next step
would have been to ask whether the MCO was a “commercial seller” of the defective services.49 In the case of an HMO or any other organization that sold
prepaid medical care rather than merely financial services, that question would
be answered in the affirmative, and the MCO and provider would be jointly liable for the defect.50 The trier-of-fact court would not have inquired as to
whether the provider was the MCO’s employee or an independent contractor.
Indeed, principles of vicarious liability would have been entirely irrelevant.
Of course, as noted above, the courts have overwhelmingly rejected the application of strict products liability to services, including medical services.51
These cases, however, did not consider whether corporate sellers of medical
services should be held liable for malpractice, that is, the physician’s negligence). Indeed, all one can infer from the cases distinguishing between products and services is that they have decisively rejected strict liability as a benchmark.52 This is significant because, as stated above, this articles thesis is that
47. Hoven v. Kelble, 256 N.W.2d 379, 391 (Wis. 1977); see also Hoff v. Zimmer, Inc., 746 F. Supp.
872, 876 (W.D. Wis. 1990); Broyles v. Brown Engineering Co., 151 So.2d 767, 771 (Ala. 1963); Gagne
v. Bertram, 275 P.2d 15, 21 (Cal. 1954); Newmark v. Gimbel’s, Inc., 258 A.2d 697, 702-03 (N.J. 1969);
Baptista v. Saint Barnabas Medical Center, 262 A.2d 902, 907 (N.J. Super. Ct. App. Div. 1970).
48. See, e.g., Hoven, 256 N.W.2d at 391; Held v. 7-Eleven Ford Store, 438 N.Y.S. 2d 976, 978 (Sup.
Ct. 1981) (considering cost of all types of services); Heirs of Fruge v. Blood Services, 365 F. Supp.
1344, 1350 (W.D. La. 1973); Shepard v. Alexian Brothers Hospital, Inc. 109 Cal. Rptr. 132, 136 (Cal.
Ct. App. 1973); Dibblee v. Dr. W. H. Groves Latter-Day Saints Hosp., 364 P.2d 1085, 1087 (Utah
1961); cf., LaRossa v. Scientific Design, Inc., 402 F.2d 937, 942 (3d Cir. 1968) (arguing that services
involve “no mass production of goods or a large body of distant consumers whom it would be unfair to
require to trace the article they used along the channels of trade to the original manufacturer and
there to pinpoint an act of negligence remote from their knowledge and even from their ability to inquire”). But see infra Part II.C. (noting MCO influence over shaping of medical services and arguing
that plaintiffs ability to recover should not depend on ability to pinpoint responsibility on either MCO
or provider). See also Greenfield, supra note 11, at 683 (“[A] surprisingly large number [of courts]
seem content to state the obvious: a sale of services is not a sale of goods. From this, the courts jump
to the conclusion that there is no warranty and no strict liability.”). Cf. RESTATEMENT (THIRD) OF
TORTS, supra note 6, § 20 note d (arguing that public policy supports hospital immunity from strict liability on the basis of holding to the effect the need for access to medical services outweighs the need
for strict liability).
49. See RESTATEMENT (THIRD) OF TORTS, supra note 6, § 1, cmt a.
50. See id; see also infra Part IV.
51. See generally supra note 6.
52. See, e.g., Hoven, 256 N.W.2d at 387 (“adoption of the plaintiff’s theory of liability . . . would set
the standard of performance for the entire medical profession at the zenith of that profession’s
achievement, a level at which by definition virtually no one could perform all the time”); id at 390-93
(listing arguments for and against strict liability); RESTATEMENT (THIRD) OF TORTS, supra note 6, §
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products liability principles support the proposition that MCOs, as corporate
sellers of medical services, impliedly warrant the quality of the services they
sell. The law of medical malpractice, of course, provides an obvious fault-based
(that is, non-strict liability) benchmark for quality.
On reflection, it is easy to see why parties to health care litigation have
rarely, if ever, argued for the imposition of an implied warranty of quality apart
from claims of strict liability. As explained above, caveat emptor has not been a
feature of malpractice law (or of the law of services in general) at least since
the time of Blackstone. There was thus no need for the nineteenth-century
courts that implied warranties of merchantability in connection with the sale of
products to employ them in service transactions. The negligence-based law of
medical malpractice was, in effect, an implied warranty of quality that predated
the industrial era. Nor was there a need for a decision like MacPherson v.
53
Buick Motor Co. to expand the universe of potential defendants in malpractice cases. Until recently, there was no distribution chain in health care; the patient bought medical services from the physician who rendered them. As a result, privity and analogous tort concepts posed no obstacle to recovery.
Even in the 1960s and 1970s, when section 402A seemed to make strict liability for medical services a possibility, privity was not a problem to plain54
tiffs. Defendants in such cases were physicians and hospitals, and each was al-

20 note d (arguing that hospital immunity comports with public policy because “the nature of the
[medical] services, the utility of, and the need for them, involving as they do the health and even survival of many people, are so important to the general welfare as to outweigh in the policy scale any
need for the imposition on dentists and doctors of the rules of strict liability in tort”) (citing Newmark
v. Gimbel’s, Inc., 258 A.2d 697, 703 (N.J. 1969)). The academic debate likewise focused on the merits
of strict liability. Compare Chait, supra note 25 and Greenfield, supra note 11, with Richard A. Epstein, Medical Malpractice: The Case for Contract, 1 AM. BAR FOUND. RES. J. 87 (1976). Courts have
occasionally articulated policy concerns linked more closely to “seller accountability” in the course of
deciding “hybrid” cases. In some of these cases, these policies are used to justify imposing strict liability on the hospital as a seller. See, e.g., Grubb v. Albert Einstein Med. Ctr., 387 A.2d 480 (Pa. Super.
Ct. 1978). Cases noting “seller accountability” principles but rejecting strict liability refer to the absence of a distribution chain in the service setting. See, e.g., LaRossa v. Scientific Design Co., 402 F.2d
937, 942 (3d Cir. 1968) (“Professional services do not ordinarily lend themselves to the doctrine of tort
liability without fault because they lack the elements which give rise to the doctrine. There is no mass
production of goods or a large body of distant consumers whom it would be unfair to require to trace
the article they used along the channels of trade to the original manufacturer and there to pinpoint an
act of negligence remote from their knowledge and even from their ability to inquire.”). Once MCOs
become involved in the provision of health care, however, a distribution chain is created. See infra
Part II.C. (applying seller accountability principles to MCOs); infra Part IV (describing operating
MCOs).
53. 111 N.E. 1050 (N.Y. 1916).
54. The “seller accountability” principles discussed in Part II.C. could conceivably have been applied in the 1960s and 1970s so as to permit recovery against hospitals for physician negligence. This
would have been a substantially larger expansion of liability than the one proposed in this article, however, for two reasons: (1) Hospitals did not sell physician services; with the exception of some hospitalbased physicians, doctors enjoyed complete financial independence from the hospitals at which they
practiced; see James F. Blumstein & Frank A. Sloan, Antitrust and Hospital Peer Review, 51 LAW &
CONTEMP. PROBS. 7, 16-17 (Spring 1988); (2) Hospitals exercised relatively little control over staff
physicians, see Hall, supra note 19, at 525-32. While it would be difficult to characterize a hospital as a
seller of physician services in most cases even today, a hospital might well assume such liability by virtue of its participation in a physician-hospital organization (PHO) or other MCO. Implied warranty
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ready accountable to injured consumers. Strict liability merely promised to
make recovery against these defendants easier by reducing the plaintiff’s burden of proof. By the 1970s, a few HMOs had been formed, but these early ventures were primarily clinics whose physicians were full-time employees.55
Again, because of the actual employment relationship, corporate liability was
not an issue. MCO liability has become a concern only in recent years as
MCOs with relatively loose provider relationships have intervened in physician-patient relationships and taken a more aggressive hand in “managing
care.”
One might have expected that the recent advent of complex distribution
systems for medical services would have led courts and litigants to imply warranties of quality against MCOs in short order. Again, however, because of the
absence of any distribution chain in the sale of medical services and because of
cases that seemed to hold that “products liability law” only applies to
“products” and not to “services,” this has not yet been the case. I argue below
that both existing legal principles and policy considerations support holding
MCOs to an implied warranty of quality.
C. The Principle of Seller Accountability
Properly understood, products liability law actually provides affirmative
support for the implication of a warranty of quality against MCOs. The implied
warranty of quality involves nothing more (or less) than the application to
MCOs of conventional principles of commercial seller accountability for personal injury, with the physician’s negligence—rather than strict liability—
serving as the benchmark against which the quality of medical services is measured. Under these conventional rules of accountability, MCOs should be liable
if they sell “defective” services (that is, services that do not conform to the
malpractice standard of care), regardless of whether the plaintiff can show that
the MCO itself has acted unreasonably.
The seller accountability strand of products liability law deals primarily with
the question of which parties will be held responsible for personal injuries
arising out of product defects. As explained earlier, under the rule of Winter56
bottom v. Wright, a plaintiff could not recover for product injuries in tort unless in privity of contract with the tortfeasor. In McPherson v. Buick Motor Di57
vision Co., Judge Cardozo rescinded this rule, permitting injured plaintiffs to
recover from manufacturers that were “upstream” in the distribution chain.
With the advent of strict liability, seller accountability principles were also in-

theory might also be applied to hold hospitals liable for torts of hospital-based physicians, such as
emergency-room staff.
55. See Clark C. Havighurst, HMOs and the Market for Health Services, 35 LAW & CONTEMP.
PROBS. 716, 718-20 (Autumn 1970) (describing early HMOs); Note, The Role of Prepaid Group Practice in Relieving the Medical Care Crisis, 84 HARV. L. REV. 887, 901-921 (1971) (same).
56. 152 Eng. Rep. 402 (1842).
57. 111 N.E. 1050 (N.Y. 1916).
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voked to permit recovery against non-negligent “downstream” parties, such as
nonmanufacturing retailers.58 Under current rules, any seller of a defective
product is liable for product defects.
The seller accountability cases that present the clearest analogy to MCO
relationships with affiliated providers are those holding a manufacturer liable
for defective components made by others but included in the manufacturerdefendants product. MCOs sell a single package of health coverage that combines the traditionally separate elements of health care finance and delivery.59
Medical services are the primary “components” incorporated into the MCO’s
product. In some cases, an MCO’s network will include a full range of institutional and professional providers; in others, it will include some lesser subset,
such as primary care or specialist services.60
Courts routinely hold manufacturers liable for defects in components incorporated into the manufacturer’s product, even when the defect can be traced to
the maker of the component. Liability is supported by a number of considerations. First, “the assembler is in the best position to evaluate the safety of the
use of a component part in its final product and can exert power over component manufacturers to ensure the safety of parts.”61 Second, “the manufacturerassembler’s act of putting its name on a product and placing it in the stream of
commerce induces the public to purchase and use the product with the belief
that the product, as a whole, is safe and fit for its ordinary applications.”62
Third, rather than permit difficulties of proof to prevent product-injury victims
from recovery,63 “it is more just to place the burden on the various parties of
the distributional chain to ‘fight out the question of responsibility among themselves,’”64 with the expectation that the parties can negotiate efficient insurance
and indemnity arrangements.65
Each of these policies is easily applied to MCOs. Like the manufacturer
that includes components made by others in the product it sells, MCOs are in a
58. The leading case was Vandermark v. Ford Motor Co., 391 P.2d 168, 171-72 (Cal. 1964) (en
banc), which was followed in RESTATEMENT (SECOND) OF TORTS, supra note 38, § 402A, cmt. f.;
RESTATEMENT (THIRD) OF TORTS, supra note 6, § 1.
59. See Part IV infra.
60. See Jonathon Weiner & Gregory de Lissovoy, Razing a Tower of Babel: A Taxonomy for
Managed Care and Health Insurance Plans, 18 J. HEALTH POL. POL’Y & L. 75 (1993); MANAGED
CARE, supra note 1, § 1.4.1 (describing various organizational models of HMOs), § 2.2 (describing organizational structure of PPOs), § 4.2 (describing organizational structure of direct contracting networks and company clinics), § 5.12 (describing structure physician-hospital organizations), § 5.13
(describing structure of foundation-model MCOs).
61. 1 AMERICAN LAW OF PRODUCTS LIABILITY § 8:1 (3rd ed. 1987) (citing Kealoha v. E. I.
DuPont De Nemours and Co., 844 F. Supp. 590 (D. Haw. 1994), aff’d, 82 F.3d 894 (9th Cir. 1996),
Exxon Shipping Co. v. Pacific Resources, Inc., 789 F.Supp. 1521 (D.Haw. 1991).
62. Id. (citing Morris v. American Motors Corp., 459 A.2d 968 (Vt. 1982)).
63. Cf. Saieva v. Budget Rent-a-Car, 591 N.E.2d 507 (Ill. App. Ct. 1992) (holding that plaintiff
could not recover for product defect where he could not prove product was in defective condition when
manufacturer sold it to retailer and retailer enjoyed statutory immunity from strict liability for manufacturing defects).
64. MARSHALL S. SHAPO, THE LAW OF PRODUCTS LIABILITY § 12.04[4], at 12-47 (3d ed. 1994)
(quoting Embs v. Pepsi-Cola Bottling Co., 528 S.W.2d 703, 706 (Ky. 1975)).
65. See id.; see also Embs, 528 S.W.2d at 706.
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good position both to evaluate the qualifications of the providers with whom
they contract and also to demand contract terms, such as participation in quality assurance activities, that will promote consumer safety.66 Particularly where
the MCO has a direct contractual relationship with consumers and advertises to
the public, it is likely to induce brand-name reliance that further justifies an
obligation on its part to stand behind its product.
Moreover, as the seller of a package of financial and medical services, an
MCO cannot avoid shaping the quality of those services. If it is to receive any
benefit from its organizational structure, it must, at a minimum, contract with
some providers and not others and settle on a mechanism for paying them.
Even these basic decisions can be quite significant. For example, an MCO
might select providers solely on the basis of their willingness to make price
concessions without regard to their reputation for quality, and its decisions
about the size and composition of its provider network will affect its members’
access to both primary and specialty care.67 The payment mechanisms it uses
will create financial incentives that will powerfully affect physician decisions in
many cases.68
Whether they elect to use their authority or not, MCOs are in a position to
enhance the quality of care their members receive or to undermine it: MCOs
can monitor provider performance only with a view to the plan’s bottom line or
they can use monitoring methods to improve quality; they can adopt practice
policies to rationalize physician behavior or they can implement a capitated
payment system and disclaim any further interest in “medical” decisions; they
can limit referrals to specialists unduly, appropriately, or not at all. MCOs cannot avoid “interfering” in medical decision-making by adopting a “hands off”
policy once their payment arrangements are in place; their policies will have already affected the identity of the medical decision maker, how and how much
he will be paid, the setting in which treatment will be delivered, and other important components of the service.
66. Not only do MCOs regularly require participation in quality assurance activities, see, e.g.,
MANAGED CARE, supra note 1, § 2.9.2 (describing typical PPO contract terms), they sometimes specifically tell a physician to make one medical decision and not another. Perhaps the most common example of such a directive would be a contractual requirement that a physician prescribe only from an
approved prescription drug formulary. See, e.g., Russell A. Jackson, MCOs Accounting for a Growing
Portion of the Pharmacy Pie, MANAGED CARE OUTLOOK, June 27, 1997, although plans have also required participating providers to follow practice guidelines, and MCOs often have “policy manuals”
affecting routine issues arising in medical practice. See Alice G. Gosfield, Measuring Performance and
Quality: The State of the Art and Legal Concerns, HEALTH LAW HANDBOOK 55-60 (1995); Julie A.
Jacob, Some Insurers Revise Mammography Coverage Polices, AM. MED. NEWS, May 19, 1997, at 5.
67. See generally John Blum, The Evolution of Physician Credentialing into Managed Care Selective Contracting, 22 AM. J. L. MED. 173 (1996).
68. A health plans decision to shift from fee-for-service payment to capitation, for example, radically changes the economic incentives facing physicians. WALTER A. ZELMAN, THE CHANGING
HEALTH CARE MARKETPLACE 49-67 (1996); Clark C. Havighurst, Making Health Plans Accountable
for the Quality of Care, 31 GA. L. REV. 587, 595-606 (1997); Andrew Ruskin, Capitation: The Legal
Implications of Using Capitation to Affect Physician Decision-Making Processes, 13 J. CONTEMP.
HEALTH L. & POLY 391, 411-19 (1997). Some health plans are now experimenting with fine-tuning
incentive payment mechanisms so that physicians would have economic incentives to adjust their behavior to take into account not only cost, but quality and consumer satisfaction as well.
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Where an MCO has engaged in the business of selling medical services and
a patient is severely injured on account of a defect in those services (that is,
medical negligence), the plaintiff’s ability to recover should not depend on
whether he can meet the rigid tests of vicarious liability law or prove that some
cost-containment strategy or other practice of the MCO was negligent. The
seller accountability principles confirm that when the MCO and its affiliated
providers fail to provide services that conform to minimum quality standards, it
should not fall to the plaintiff to determine which of the possible defendants is
most responsible.
Defendants in implied warranty cases can be expected to argue that the appropriate analogy is not between MCOs and product manufacturers but rather
between MCOs and retailers who are uninvolved in the manufacturing process.
While this distinction would be irrelevant under the law of most states, some
courts have been hesitant to impose liability on retailers with no means of influencing the product design or manufacturing process.69 A similar impulse has
led some state legislatures to grant a degree of immunity to nonmanufacturing
product retailers.70
In light of the MCO’s ability to influence the services it provides, the response to such arguments should be fairly obvious. Even if scruples about strict
liability would lead courts to absolve some nonmanufacturing retailers from liability for defective products, MCO liability should be unaffected. MCOs may
be irresponsibly indifferent about the quality of services their physicians provide,71 but they cannot persuasively argue that they exert no influence over the
shape of those services. For this reason, legal rules (whether judge-made or
statutory) that exonerate nonmanufacturing retailers should not apply to
MCOs.

69. As a general rule, retailers, like other commercial sellers are liable for product defects caused
by other parties in the chain of distribution. RESTATEMENT (THIRD) OF TORTS, supra note 6, § 1, cmt.
e, (collecting cases and concluding that support for the rule that “any seller in the chain of distribution
(manufacturer, wholesaler, retailer) is liable for the sale of a defective product is widespread”); cmt. o
(nonmanufacturing sellers liable for defective design and inadequate instructions and warnings);
DAVID F. FISCHER & WILLIAM S. POWERS, PRODUCTS LIABILITY: CASES AND MATERIALS 588
(1988) (“The overwhelming majority of courts have followed the position taken in [Vandermark v.
Ford Motor Co., 391 P.2d 168, 171-72 (Cal. 1964)(en banc)] and cmt. f [to Section 402A] by applying
strict liability to retailers.”). Nevertheless, some state statutes evince misgivings about holding retailers liable for manufacturing defects beyond their control, immunizing nonmanufacturing sellers from
strict products liability altogether, see, e.g., GA. CODE ANN. §§ 51-11.1 (1997), or in the event the
manufacturer is subject to the courts jurisdiction and is solvent, see e.g., TENN. CODE ANN. §§ 29-28106 (Supp. 1996). See generally AMERICAN LAW OF PRODUCTS LIABILITY, supra note 61, §§ 5:14-5:19
(analyzing various state statutes). Many of the statutes conferring immunity speak in terms of the retailers ability to inspect products and suggest other analysis that is inappropriate in when services are
being sold. See, e.g., Kan. Stat. Ann. § 60-3306 (1994). Cf., SHAPO, supra note 64, at § 12.04[2][b], 1240 (“If a thread of consistency exists in results that go both for and against retail sellers, it may reside
in the degree of consumer reliance on the defendant [and] in the retailer’s opportunity to exercise control over risk.”).
70. See supra note 69.
71. Cf. Havighurst, supra note 68, at 619 n. 80 (“Because of the need to induce better oversight
and to increase selectivity, an MCO’s failure to exercise any control over the negligent doctor is a better reason to impose enterprise liability than not to.”).
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III
TOWARD AN IMPLIED WARRANTY OF QUALITY: POLICY ISSUES
A. Revisiting Enterprise Liability Policy
The preceding section argues that, contrary to prevailing assumptions, existing law supports an implied warranty of quality that obligates MCOs to sell
medical services that satisfy the existing malpractice-based standard of care.
Indeed, considering the lengths to which courts have gone to protect consumers
against personal injury in consumer product transactions, MCOs’ lack of accountability constitutes a striking departure from “normal” law. This section
considers the policy implications of holding MCOs to an implied warranty of
quality. It begins with a brief examination of the implied warranty in light of
the major policy concerns of tort law—deterrence, compensation, efficiency,
and fairness. The bulk of this section is then devoted to a comparison of the
implied warranty of quality with other common law theories of MCO liability.
A substantial body of literature endorses MCO liability for physician malpractice from a policy perspective.72 This literature developed primarily in connection with various legislative proposals for “enterprise medical liability,” especially the proposal of President Clinton’s Health Care Task Force. Although
these legislative proposals differ in some respects from the implied warranty of
quality advocated here, most commentators have concluded that imposing
automatic liability on MCOs for the malpractice of their physicians would represent a significant improvement over the status quo.73
The case for focusing liability on MCOs is straightforward and consistent
with the policies underlying enterprise liability in the products context.74 First
72. See 2 THE AMERICAN
FOR PERSONAL INJURY 111-26

LAW INSTITUTE, REPORTERS STUDY: ENTERPRISE RESPONSIBILITY
(Paul C. Weiler ed. 1991) [hereinafter ALI REPORTERS STUDY]; Kenneth S. Abraham et al., Enterprise Responsibility for Personal Injury: Further Reflections, 30 SAN
DIEGO L. REV. 333 (1993); Kenneth S. Abraham & Paul C. Weiler, Enterprise Medical Liability and
the Choice of the Responsible Enterprise, 20 AM. J. L. & MED. 29 (1994)[hereinafter Choice of the Responsible Enterprise]; Abraham & Weiler, Enterprise Medical Liability, supra note 2, at 382-84;
Havighurst, supra note 68; William M. Sage et al., Enterprise Liability for Medical Malpractice and
Health Care Quality Improvement, 20 AM. J. L. & MED. 1 (1994); Paul C. Weiler et al., Proposal for
Medical Liability Reform, 267 J. AM. MED. ASSN 2355 (1992). But see Patricia M. Danzon, Tort Liability: A Minefield for Managed Care?, 26 J. LEG. STUD. 491 (1997). The ALI Reporters’ Study proposed hospital-based, rather than health-plan-based enterprise liability. 2 ALI R EPORTERS’ STUDY,
supra, at 113. However, its authors acknowledge that either strategy would represent an improvement
over the status quo. See Abraham & Weiler, Enterprise Medical Liability, supra note 2, at 415. For a
debate over the merits of delivery-based versus finance-based enterprise medical liability, see id. at
415-19; Abraham & Weiler, Choice of the Responsible Enterprise, supra; Sage et al. supra.
73. See generally Sage et al., supra note 72; Abraham & Weiler, Enterprise Medical Liability, supra
note 2, at 415.
74. These include, for example, protecting consumers from avoidable injuries. See Escola v. CocaCola Bottling Co. of Fresno, 150 P.2d 436, 441 (Cal. 1944) (“It is to the public interest to discourage
the marketing of products having defects that are a menace to the public.”); KEETON ET AL., supra
note 26, § 98, at 693 (citing Phillips v. Kimwood Machine Co., 525 P.2d 1033, 1041-42 (Or. 1974); First
National Bank of Albuquerque v. Nor-Am Agricultural Products, Inc., 88 N.M. 74, 537 P.2d 682
(1975)), assuring their compensation when such injuries occur, see Escola, 150 P.2d at 441, spreading
losses efficiently, see id; Goldberg v. Kollsman Instrument Corp., 191 N.E.2d 81, 83 (N.Y. 1963);
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and foremost, MCO liability is likely to reduce preventable medical injuries.
Individual malpractice premiums are almost never experience-rated; focusing
liability on MCOs would permit experience rating (or its equivalent) at the
MCO level and thus give MCOs additional economic incentives to prevent injuries.75 In addition, MCOs are substantially better positioned than are physicians to engage in systematic efforts to improve quality.76 Institutional liability
would also help rationalize MCOs’ cost-containment mechanisms. At present,
MCOs that are not vicariously liable for provider malpractice have only attenuated economic incentives to consider the likelihood that MCO policies
77
might contribute to negligent physician decision-making and patient injury. If
MCOs were automatically liable for physician negligence, they would have an
additional incentive to consider the likelihood that a payment mechanism or
other policy would increase the MCO’s liability.78

Greenman v. Yuba Power Products, Inc., 377 P.2d 897, 901 (Cal. 1962); Greenfield, supra note 11, at
688, skepticism about consumers’ ability to evaluate increasingly complex products, see Greenman, 377
P.2d at 901; David G. Owen, The Intellectual Development of Modern Products Liability Law: A
Comment on Priests View of the Cathedrals Foundation, 14 J. LEGAL STUD. 529 (1985), skepticism of
their ability to bargain effectively with distant corporate sellers, see Priest, supra note 12, at 520, the
unfairness of applying caveat emptor in the face of sophisticated marketing campaigns, see generally id;
see also Gregory C. Keating, The Idea of Fairness in the Law of Enterprise Liability, 95 MICH. L. REV.
1266 (1997); David G. Owen, The Moral Foundation of Product Liability Law: Toward First Principles,
68 NOTRE DAME L. REV. 427 (1993), and the undue cost of litigating the fault issue, see KEETON ET
AL., supra note 26, at 693 (citing Phipps v. General Motors Corp., 363 A.2d 955 (Md. 1976)); Greenfield, supra note 11, at 688.
75. See ALI REPORTERS STUDY, supra note 72, at 123-24; Abraham & Weiler, Enterprise Medical
Liability, supra note 2, at 410-15; Havighurst, supra note 68, at 618 n. 79 (“An important practical consideration strongly arguing for enterprise liability is that MCOs, if they were routinely liable for physician torts, would have stronger financial incentives to maintain quality than do individual physicians,
who generally carry liability insurance that cushions the effect of any judgment and is not sufficiently
experience-rated to cause the doctor to recognize or modify risky behavior.”).
76. See Havighurst, supra note 68, at 619 n. 80 (“Because of the need to induce better oversight
and to increase selectivity, an MCOs failure to exercise any control over the negligent doctor is a better reason to impose enterprise liability than not to.”); Sage et al., supra note 72, at 11-12 (noting
health plans ability to influence care through contractual arrangements with providers and
“gatekeepers”), 14 (“Health plans should be more efficient quality managers because institutions are
better able than individual practitioners to view the quality of care they deliver in the aggregate, have
the financial resources to develop medical information systems, and can more easily implement programs for ‘total quality management’ (TQM) or ‘continuous quality improvement’ (CQI).”), 15
(noting health plans’ ability to facilitate physician-patient communication and thereby reduce malpractice exposure, to identify and deal with substandard practitioners, and provide consumers with better
information); William M. Sage & James M. Jorling, A World That Wont Stand Still: Enterprise Liability By Private Contract, 43 DEPAUL L. REV. 1007, 1016 (1994) (“[E]xisting managed care contracts can
address quality monitoring, clinical performance, accountability for error and dispute resolution procedures.”), nn. 56-60 (providing sample contractual provisions); but see Sage et al., supra note 72, at 23
(recognizing that some MCOs “may not be immediately capable of performing good quality control”).
See generally Barry R. Furrow, The Changing Role of the Law in Promoting Quality in Health Care:
From Sanctioning Outlaws to Managing Outcomes, 26 HOUSTON L. REV. 147 (1989).
77. MCOs have a market incentive to do so, but consumers lack of information about plan quality
reduces this incentive. Patients that are injured may also incur additional medical costs which the plan
must cover. See Sage & Jorling, supra note 76, at 1017 (1994) (reporting that additional medical expenses caused by medical malpractice comprise about 25 percent of all damages). In addition, some
cost containment mechanisms might constitute direct negligence on the MCOs part.
78. See Sage et al., supra note 72, at 7 (“If the organizational unit responsible for delivering cost-
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In addition, MCO liability would facilitate compensation for the relatively
small number of injured plaintiffs who are entitled to damages that exceed the
policy limits of their physicians’ professional liability insurance policies.79 More
significantly, because MCOs will often serve larger risk pools than are available
to conventional physician malpractice insurers, MCO malpractice insurance
should be subject to more efficient underwriting than individual professional
liability policies.80 The comparative advantage of MCOs as risk-bearers creates
an incentive for physicians and MCOs to bargain for wealth-increasing indemnity and insurance arrangements.81
Litigating the issue of MCO liability is also likely to be wasteful. Litigation
over whether the negligent physician was the (actual or apparent) agent of the
MCO or over whether the MCO was independently negligent makes malpractice litigation costly82 and may have a chilling effect on the MCO’s quality assurance procedures.83 In addition, if MCOs were automatically liable for physician negligence, many of the costs associated with multiple-defendant
litigation—such as increased legal fees, the monitoring of costs, and the difficulties associated with settlement84—might be eliminated by contractual indemnities between the MCO and its providers.
MCO liability is also appropriate as a matter of fairness.85 Indeed, misgiv-

effective care does not suffer financial loss when its attempts to control utilization result in more severe morbidity, it will fail to take appropriate precautions in designing and implementing costcontainment policies.”).
79. See Abraham & Weiler, Enterprise Medical Liability, supra note 2, at 391 & n.41, 402-03 & nn.
81-82.
80. Malpractice insurers’ risk pools are relatively small because they are limited to physicians who
(1) practice the same specialty (2) in the same state (3) that have coverage with the particular insurer.
See Abraham & Weiler, Enterprise Medical Liability, supra note 2, at 401.
81. One might well ask why, if this is true, MCOs and their physicians have not already contracted
for MCOs to bear malpractice liability. See, e.g., Danzon, supra note 72, at 515. One possible answer
is that reorganizing the fee structure and existing insurance mechanisms would be unduly costly to
loosely affiliated MCOs given their existing immunity from liability. Cf. ALI REPORTERS’ STUDY,
supra note 72, at 121 (describing “the major transaction costs of reconstructing all the reimbursement
schedules [as] a potent inertial force in favor of the legal status quo”). Note that such contractual arrangements are in fact sometimes observed when an institution is automatically liable for its providers
negligence. See Sage et al., supra note 72, at 17-18 (describing “channeling” arrangements in teaching
hospitals and voluntary assumption of liability by some MCOs and other entities); Sage & Jorling, supra note 76, at 1034-37 (same).
82. Cf. Abraham & Weiler, Enterprise Medical Liability, supra note 2, at 391-92 (evaluating effects of proof requirements in litigation against hospitals). Because plaintiffs seeking to hold MCOs
and hospitals liable for a physician’s malpractice generally employ the same legal theories, see
Havighurst, supra note 68, at 607, the same analysis applies.
83. See Abraham & Weiler, Enterprise Medical Liability, supra note 2, at 392 (analyzing hospital
litigation). The similarity of peer review mechanisms in hospitals and MCOs suggests that this observation applies equally to MCOs.
84. See ALI REPORTERS’ STUDY, supra note 72, at 119; Abraham & Weiler, Enterprise Medical
Liability, supra note 2, at 406; Havighurst, supra note 68, at 606; Sage, et al., supra note 72, at 19.
85. See Barry R. Furrow, Managed Care Organization and Patient Injury: Rethinking Liability, 31
GA. L. REV. 419, 457 (1997); Vernellia R. Randall, Managed Care, Utilization Review, and Financial
Risk-Shifting: Compensating Patients for Health Care Cost-Containment Injuries, 17 U. PUGET SOUND
L. REV. 1, 8 (1993); but see Abraham & Weiler, Enterprise Medical Liability, supra note 2, at 399-400
(arguing that “individual physicians do not ‘correct’ any particular ‘injustice’ they may have commit-
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ings about the legitimacy of managed health care as a means of providing medical services are magnified by MCOs’ lack of tort accountability.86 MCOs exert
tangible control over physician behavior, both directly—through medical policies and directives87—and indirectly—through payment methodologies88 and the
threat of deselection.89 MCO policies can also affect the medical care patients
receive even when such policies do not affect physician behavior. By contracting with only a select group of providers in any given community, an MCO either restricts use of, or gives its members incentives not to choose, providers
whose services may be of higher quality, yet more expensive to the plan. As
explained in some detail below, the vicarious liability analysis courts routinely
employ in MCO liability cases makes it quite difficult for patients to hold
MCOs accountable even when their policies directly contribute to physician
negligence.
One may anticipate a number of policy arguments against imposing an implied warranty of quality on MCOs. The first is an extension of the critique of
products liability law offered by George Priest and others challenging the
manufacturing enterprise’s efficiency as a risk-spreader, its capacity to respond
optimally to the safety incentives created by the tort regime, and the existence
of meaningful information and bargaining power problems in consumer prod90
uct transactions. Whatever the ultimate force of this critique in the products
91
liability context, arguments alleging over-deterrence and inefficient manda-

ted”).
86. Havighurst, supra note 68, at 590-95.
87. See generally supra note 66.
88. See generally supra note 68.
89. The threat of “deselection” is an important source of economic leverage over physicians. See
John D. Blum, The Evolution of Physician Credentialing into Managed Care Selective Contracting, 22
AM. J. L. & MED. 173, 195 (1996). As long as patients covered by any given payor do not represent
too great a proportion of a physician or groups practice, the threat of deselection may exert only a
mild influence. Where a plan has a large market share or where a physician is otherwise dependent on
a particular plan, however, exclusion can spell financial ruin. Highly developed information systems
now enable plans to develop detailed profiles of the services physicians order for plan patients. Cost
and quality profiling increasingly serve as the basis upon which plan administrators decide with which
physicians they will contract. See, e.g., Linda O. Prager, Oxford’s Gambit: Specialist Teams, DoctorSpecific Data, AM. MED. NEWS, May 19, 1997, at 1. In addition, health plans appear more willing to
contract with a large number of providers when they are attempting to establish a presence in a given
market; once the plan’s market share develops, they may find it advantageous to reduce the size of
their networks in order to reduce administrative costs and in order to negotiate more favorable payment terms with the remaining providers. Especially in areas where there is a surplus of physicians,
loss of participating provider status can have dramatic economic effects on a physician. Physicians
may thus have strong incentives to conform to plan expectations concerning utilization of services,
even if a plan has relatively few explicit mechanisms in place to control physician treatment patterns.
See generally Uwe Reinhardt, Reorganizing Financial Flows in American Health Care, HEALTH AFF.
172 (Supp. 1993) (describing effect of MCOs on physician labor markets).
90. See, e.g., George L. Priest, The Current Insurance Crisis and Modern Tort Law, 96 YALE L.J.
1521 (1987); George L. Priest, Modern Tort Law and its Reform, 22 VAL. U. L. REV. 1 (1987); Alan
Schwartz, Proposals for Products Liability Reform: A Theoretical Synthesis, 97 YALE L.J 353 (1988).
91. See Steven P. Croley & Jon D. Hanson, Rescuing the Revolution: The Revived Case for Enterprise Liability, 91 MICH. L. REV. 683 (1993) (defending enterprise liability against efficiency critique);
Gregory C. Keating, The Idea of Fairness in the Law of Enterprise Liability, 95 MICH. L. REV. 1266
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tory insurance lose some of their force given the implied warranty’s use of a
negligence standard as the benchmark against which MCP services are to be
measured. To be sure, MCO liability for physician negligence is “strict” in the
sense that proof of direct negligence on the part of the MCO is not required.
However, even in this regard, the implied warranty bears a much stronger resemblance to the relatively noncontroversial principles of corporate vicarious
92
liability than it does to the defect-oriented inquiry of products liability law.
One might also expect a slippery slope challenge to the implied warranty,
arguing that it could not be coherently limited to MCOs and would thus expose
service firms in other sectors to unwarranted liability. This objection is unlikely
to be of practical significance. First, the tort-based implied warranty advocated
here applies only to personal injury claims. Moreover, given its origins in the
unusual hybrid tort-and-contract theory of traditional malpractice law, the implied warranty may well be considered sui generis. In addition, most firms that
sell services use employees rather than independent contractors to do so and
are thus already liable on theories of actual or apparent agency for those employees’ torts. Finally, even a firm that resells the services of independent contractors will often be held liable for its contractor’s negligence under the nondelegable duty doctrine if rendition of the services involves a substantial risk of
93
personal injury to consumers.
Significantly, the consumer protection effects gained by imposing a warranty on MCOs could be achieved without substantially diminishing consumers’
choices in the marketplace. Providers and consumers that objected to the degree of corporate intervention in health care that would follow automatic MCO
liability could choose a traditional indemnity insurance product that allowed
free choice of physician and that relied on traditional utilization review to contain costs. The only option that would become harder to find in the market
would presumably be managed care products offered by MCOs with a “handsoff” attitude toward quality assurance. At present, it is difficult to see why a
consumer would prefer a health plan that could take quality-decreasing cost94
containment measures without regard to resulting personal injuries. Indeed,
one suspects that such plans trade on the frequent misperceptions (willfully
created in the days when medicine was privately regulated by the medical profession) that all medical care is created equal, so that consumers do not under-

(1997) (defending enterprise liability on fairness grounds).
92. For a critical appraisal of the policy justifications underlying vicarious liability law, see Gary T.
Schwartz, The Hidden and Fundamental Issue of Employer Vicarious Liability, 69 S. CAL. L. REV. 1739
(1996).
93. The nondelegable duty doctrine is considered in Part III.B.3. infra.
94. One reason might be the deep pocket effect of MCO liability. See infra text accompanying
notes 108 through 110. This might conceivably raise the price of MCO coverage by an amount greater
than the quality gains the MCO could accomplish with aggressive management. Consumers might also
rely on the market as a quality assurance check on MCO cost containment policies with bad quality
effects. However, information problems cast doubt on this strategy.
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stand that they are getting lower quality medicine for their lower premium.
Another plausible objection to the implied warranty of quality is that it may
well be a second-best solution to the problem of MCO immunity. Because it is
a judge-made remedy, it would differ from legislative proposals for enterprise
medical liability (“EML”) in that it presumably would not make MCOs exclusively liable for physician malpractice. Exclusive MCO liability is arguably
preferable from an efficiency perspective because MCOs are likely to be more
efficient insurance purchasers than physicians, and because litigation costs
would be reduced if only one entity were the target of each malpractice suit.96
Providers who are not relieved of malpractice liability may need to continue
purchasing individual professional liability coverage, reducing potential efficiency gains.97
Also, if physicians remain liable for malpractice, MCOs may elicit promises
of indemnity from affiliated doctors, thereby reducing the MCO’s incentive to
take all reasonable steps within its power to improve the quality of the services
it sells.98 Finally, doctors that face continued liability may be more likely to resist reasonable cost-containment measures on defensive medicine grounds, and
some of the potential for improvement in relations between corporate managers and health care professionals may be lost.99
On the other hand, the increased cooperation between MCO physicians and
corporate managers intent on increasing the bottom line that would presumably result from statutory EML proposals is not an unmixed blessing. One benefit of a common law warranty is that it continues the physician’s malpractice liability and thus his incentive to advocate for the patient.100 The very nature of
corporate medical practice suggests that physicians will have personal incentives not to resist corporate directives to control costs. Continuing physician
liability for medical malpractice, including a duty to advocate for patients
within the plan’s administrative framework101 will provide at least some coun95. This problem may be exacerbated by the employees’ financial incentives to minimize health
care costs. See Dayna B. Matthew, Controlling the Reverse Agency Costs of Employment-Based Health
Insurance of Markets, Courts, and a Regulatory Quagmire, 31 WAKE FOREST L. REV. 1037 (1996).
96. See Sage et al., supra note 72, at 19-20; Abraham & Weiler, Enterprise Medical Liability, supra
note 2, at 406.
97. See Abraham & Weiler, Enterprise Medical Liability, supra note 2, at 420-21 (arguing that
hospital-based enterprise liability should extend to services provided outside the hospital for this reason).
98. See Sage et al., supra note 72, at 21 (arguing that EML schemes should forbid indemnification
of MCOs by physicians).
99. See id. at 12-13 (arguing that one of the virtues of enterprise medical liability is its potential to
improve MCO/physician relations).
100. But see ALI REPORTERS’ STUDY, supra note 72, at 121-26 (arguing that exclusive enterprise
medical liability need not make physicians indifferent to the quality of care they provide).
101. See Havighurst, supra note 68, at 640-43 (“[A] doctor should be expected to advocate dutifully
and competently, within whatever machinery the plan provides, any plausible claim the patient might
have to have a needed service paid for by the plan, calling all relevant information to the attention of
the utilization manager.”); see also Wickline v. State, 192 Cal. App. 3d 1630, 1645-46 (Cal. Ct. App.),
review granted, 727 P.2d 753 (Cal. 1986), review dismissed and case remanded, 741 P.2d 613 (Cal.
1987).
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terweight to the pressure corporate managers will inevitably exert. While a
fully adversarial relationship may not be desirable, the Achilles’ heel of managed health care may well be its tendency to undermine physicians’ loyalty to
their patients. Retention of malpractice liability certainly will not alleviate this
problem entirely, but it may help provide needed reinforcement of this important professional ethic.
Another reason not to be concerned about the alleged inefficiency of the
implied warranty of quality as compared with legislative EML proposals is that
exclusive MCO liability can be implemented by contract.102 MCOs could simply
agree to indemnify their providers completely against medical malpractice
103
claims.
While the providers would still face formal liability and the embarrassment of malpractice litigation, indemnities would probably enhance cooperation between MCOs and providers. Indeed, many teaching hospitals, which
are more likely to have actual master/servant relationships with their physicians
and thus to be liable for their torts, currently employ channeling and other arrangements that substantially resemble EML by contract.104
The implied warranty of quality might also be criticized as a “second-best”
prescription for MCO accountability in light of the deficiencies of the malprac105
tice system. Malpractice law is a blunt instrument; questions of medical fault
push jury competence to the limit, and many people assume juries are incapable of making the cost-benefit tradeoffs that are implicit in the very concept of
106
managed health care. Given these limitations, why place additional reliance
on malpractice law?
The question should not be framed as whether the implied warranty standing alone is the ideal solution to the new malpractice problems presented by
managed care. Rather, the warranty must be compared in the first instance to
courts’ other options for dealing with questions of MCO accountability. I have
argued that the implied warranty is superior to a rule of no accountability from
both a positive and a normative perspective, and I will argue below that it is
102. See generally Sage & Jorling, supra note 76, Abraham & Weiler, Enterprise Medical Liability,
supra note 2, at 429.
103. In some cases, indemnities might well run in favor of the MCO. Some institutional providers
such as hospitals may be more efficient risk bearers than some MCOs. Sage et al., supra note 72, at 23.
Indeed, the joint and several liability which an implied warranty would create might facilitate efficient
contractual arrangements that might not occur under “exclusive” enterprise medical liability proposals. See id. (arguing that emerging MCOs might lack the bargaining power required to get more efficient institutional risk bearers to assume liability and suggesting a transition period of joint and several
liability among MCOs and other institutional service providers).
104. See Sage et al., supra note 72, at 17-18; Sage & Jorling, supra note 76, at 1026. A “channeling”
arrangement involves a health care enterprise purchasing malpractice insurance for affiliated and employed physicians. Thereafter, affiliated physicians do not carry individual medical malpractice insurance, but, instead, are covered under the health care enterprise insurer. The result is that when a suit
arises, there is one insurer for both the physician and the health care enterprise.
105. See, e.g., Gary T. Schwartz, A National Health Care Program: What Its Effect Would Be on
American Tort Law and Malpractice Law, 79 CORN. L. REV. 1339, 1373 (1994) (noting that malpractice law is a possible solution to problems created by health care cost-containment, but questioning
whether it is an intelligent solution).
106. See id.
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comparatively superior to other existing legal doctrines. However, combining
the implied warranty with, say, regulatory or contractual mechanisms for ap107
proving specific cost-benefit tradeoffs might ultimately prove desirable.
A final drawback of the implied warranty of quality may be its tendency to
increase costs by inducing malpractice litigation that would otherwise not occur. While many patients feel a natural resistance to sue their personal physicians, there is reason to believe they may be less reticent if the potential defendant is a large corporation. Of course, a patient’s reticence about bringing suit
is not always warranted, so some portion of any increase in the number of lawsuits brought against MCOs may well represent an improvement in the system.108 Nevertheless, there is a widespread and potentially justified concern
that the cost of health care might be increased needlessly by a proliferation of
either meritless litigation, excessive damage awards, or both.109
Despite these difficulties, the choice to be made is not necessarily between
continuing unwarranted MCO immunity and opening the floodgates of abusive
litigation. The “deep pocket” issue affects all types of businesses that operate
in corporate forms. As courts and legislatures move to resolve the controversy
over large and unpredictable damage awards, the solutions they develop should
affect litigation against health care firms no less than any other business enterprise.110
B. MCO Liability in the Courts
MCO liability for physician negligence is not only good policy; it is also
107. See id. at 1347.
108. See Sage, et al., supra note 72, at 19 (arguing that one benefit of enterprise medical liability is
reduction in transaction costs facing injured plaintiffs).
109. See Michael Rustad & Thomas Koenig, Reconceputalizing Punitive Damages in Medical Malpractice: Targeting Amoral Corporations, Not “Moral Monsters,” 47 RUTGERS L. REV. 975, 1015-17
(1995) (arguing generally that concern over excessive punitive damage awards is unjustified in light of
empirical studies, but conceding that “[o]verkill may become an issue in future cases involving
HMOs”); but see NEIL VIDMAR, MEDICAL MALPRACTICE AND THE AMERICAN JURY: CONFRONTING THE MYTHS ABOUT JURY INCOMPETENCE, DEEP POCKETS AND OUTRAGEOUS DAMAGE
AWARDS 259-61 (1995) (concluding that empirical research “does not support the widely made claims
that jury damage awards are based on the depth of defendants’ pockets, sympathies for plaintiffs, caprice or excessive generosity”). At present, punitive damages do not constitute an important element
of health care costs. See PAUL C. WEILER, MEDICAL MALPRACTICE ON TRIAL 4 (1991); Rustad &
Koenig, supra, at 989. Erratic damages do appear to present a problem. See Kenneth S. Abraham et
al., Enterprise Responsibility for Personal Injury: Further Reflections, 30 SAN DIEGO L. REV. 333, 339
(1993); Thomas B. Metzloff, Resolving Malpractice Disputes: Imaging the Jury’s Shadow, 54 LAW &
CONTEMP. PROBS. 43, 84-88 (Winter 1991); Paul C. Weiler, Fixing the Tail: The Place of Malpractice in
Health Care Reform, 47 RUTGERS L. REV. 1157, 1173-74 (1995). Although it is impossible to predict
how the introduction of corporate defendants will affect malpractice litigation, anecdotal evidence
does suggest cause for concern that large damage awards might have a non-negligible effect on health
care costs. See, e.g., Fox v. Health Net, No. 219692 (Riverside Co. Sup. Ct., Dec. 28, 1993) (jury
awarded $12 million compensatory damages and $77 million punitive damages in connection with
HMO medical director’s refusal to authorize bone marrow transplant).
110. See, e.g., Abraham & Weiler, Enterprise Medical Liability, supra note 2, at 404-06 (advocating
pain and suffering damages guidelines); Sage et al., supra note 72, at 21-22 (suggesting cap on noneconomic damages). In addition, the implied warranty theory could potentially reduce litigation over
the legitimacy of payment mechanisms.
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good law, especially when compared to other legal mechanisms for holding
MCOs accountable for medical malpractice. The most obvious doctrinal alternative to the implied warranty of quality is a broadening of existing vicarious
liability rules in order to reach MCO defendants.111 As explained earlier,
MCOs are presently liable for physician malpractice only when an actual or apparent employment relationship exists, when the MCO is itself negligent, or in
a few other exceptional circumstances, such as when the principal’s duty is
deemed to be nondelegable or when the activity involved is abnormally dangerous. Several courts and commentators have proposed either expanding the
existing tests for actual or apparent control or including medical practice in one
of the “exceptional” categories. While either of these strategies would represent an improvement over the status quo, they are inferior alternatives to the
implied warranty.
1. Expanding the “Control” Test. Historically, respondeat superior has
rarely been applied to hold a corporation liable for the malpractice of
physicians who are not its full-time employees.112 The touchstone of vicarious
liability is control, defined primarily in terms of “the details of the work,” and
the skill and financial independence of the contractor.113 Because of traditional
cultural assumptions about physician autonomy, the high degree of skill
required for medical practice, and the differing circumstances of individual
patients, managerial control over the physical details of medical practice has
been considered both impractical and unethical.114 Moreover, most physicians
111. See Glenn, supra note 2, at 339 (arguing that the “same effect” of enterprise liability “may be
achieved by applying medical tort principles to … integrated networks”).
112. But see, e.g., Schleier v. Kaiser Found. Health Plan, 876 F.2d 174 (D.C. Cir. 1989) (staff-model
HMO held liable for malpractice of non-employee physician); Dunn v. Praiss, 606 A.2d 862 (N.J. Super. Ct. App. Div. 1992), subsequent proceedings, 638 A.2d 875 (N.J. Super. Ct. App. Div. 1994), rev’d,
656 A.2d 413 (N.J. 1995) (HMO held liable for malpractice of non-employee consulting physician).
Schleier and Dunn are analyzed in some detail infra at text accompanying notes 150-61.
113. To determine whether a master-servant relationship exists under the Restatement test, courts
are to determine the following facts, among others:
(a) the extent of control which, by agreement, the master may exercise over the details of the
work;
(b) whether or not the one employed is engaged in a distinct occupation or business;
(c) the kind of occupation, with reference to whether, in the locality, the work is usually done
under the direction of the employer or by a specialist without supervision;
(d) the skill required in the particular occupation;
(e) whether the employer or the workman supplies the instrumentalities, tools, and the place
of work for the person doing the work;
(f) the length of time for which the person is employed;
(g) the method of payment, whether by the time or by the job;
(h) whether or not the work is a part of the regular business of the employer;
(i) whether or not the parties believe they are creating the relation of master and servant; and
(j) whether the principal is or is not in the business.
RESTATEMENT (SECOND) OF AGENCY § 220(2)(a-j) (1958).
114. See DAVID L. LEITNER, MANAGED CARE LIABILITY 254-256 (1997); WALTER A. ZELMAN,
THE CHANGING HEALTH CARE MARKETPLACE, PRIVATE VENTURES, PUBLIC INTERESTS 81-82
(1996); Mark A. Hall, Institutional Control of Physician Behavior: Legal Barriers to Health Care Cost
Containment, 137 U. PA. L. REV. 431, 463 (1988); Havighurst, supra note 68, at 587-88, 611;
Theo-
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(even those affiliated in some way with MCOs) maintain independent and
financially successful medical practices that serve patients with a wide variety
of insurance coverages.115 As a result, physicians who are not salaried
employees of an MCO are presumptively not under its control for vicarious
116
liability purposes.
A modified respondeat superior test presumably would approach the control issue from a more realistic vantage point, permitting injured plaintiffs to
prove MCO control on the basis of existing, indirect control mechanisms, such
as payment systems, market conditions, the threat of deselection and other
similar factors. Although a modified test would be an improvement over the
status quo, it is problematic in several respects. First, the control inquiry is
necessarily fact-specific, permitting MCOs that do not “control” their physicians to remain immune from malpractice liability. Such case-by-case linedrawing is likely to involve significant costs, especially additional litigation
costs and increased uncertainty to no apparent advantage. Also, a factintensive control inquiry can be expected to encourage MCOs to distance

dore R. Marmor et al., A New Look at Nonprofits: Health Care Policy in a Competitive Age, 3 YALE J.
ON REG. 313, 313-17 (1986).
115. See generally, Robert A. Berenson, Beyond Competition, HEALTH AFF., Mar./Apr. 1997, at
171.
116. This is not to say that MCOs are incapable of “controlling” independent physicians. See supra
note 66. An MCO that regularly offers specific directions to an independent physician (such as through
the use of formularies, practice guidelines or policy manuals) may run a significant risk of being found
to “control the physical details of the employee’s conduct.” RESTATEMENT OF AGENCY, supra note
113, § 220(2)(a). However, as described above, MCOs also use indirect means such as payment
mechanisms, monitoring and the threat of deselection to influence physicians practice. Compare
Chase, 583 N.E.2d at 254 (no vicarious IPA liability despite presence of UR policies where
“responsibility for the actual provision of medical treatment rests with [independent physician group]
and its employee-physicians”), with Sloan, 516 N.E.2d at 1109 (medical director’s judgments were final). One commentator has suggested that where cost-control mechanisms “are exercised by a physician-medical director or other medically trained personnel, the inference of control becomes even
stronger.” William A. Chittenden, III, Malpractice Liability and Managed Health Care: History and
Prognosis, 26 TORT AND INS. L.J. 451, 457 (1991). Indirect mechanisms do not usually compel a physician to make any given medical decision, although they may increase the likelihood that he will do so.
Under the traditional control test, it is not enough that the principal’s conduct be a substantial contributing factor in a given decision; control over the physical details of the employee’s conduct must be
proven.
Even an MCO that occasionally directs physician decision making may be able to defeat allegations that it controls affiliated physicians. As argued above, a principal can be deemed to control an
independent contractor if it has the contractual right to control the contractor’s decisions; actual control need not be exercised. MCOs’ ability to get physicians to agree to abide by certain practice policies or to accept a prescription drug formulary might thus reasonably be held to indicate that MCOs
possess the contractual ability to regulate physician practice, justifying liability. Even though this argument has considerable logical force, it would seem to be a hard sell as a practical matter. Despite
the widespread corporate production of other goods and services in our economy, there is a strong cultural presumption that “only individual professionals, not corporations, provide health care.”
Havighurst, supra note 68. In order to prevail on the issue of MCO control, a plaintiff must overcome
not only the MCO’s proffered evidence of physician independence, but also existing cultural and legal
presuppositions about the relative functions of physicians and corporations in the American health
care industry. Id. Given these presuppositions, MCOs may plausibly argue that their physicians’ willingness to accommodate them on a modest range of practice issues should not permit an employmentlike control relationship to be inferred.
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themselves117 from medical decision-making in the hope of avoiding liability.
This distancing could be real or only apparent. In the latter case, plans could
include self-serving contractual language or adjust their organizational structures to cloud the control issue in litigation, exacerbating the cost and uncertainty problems identified above. More troubling, however, is the prospect that
MCOs, after limiting their members access to providers and instituting potentially dramatic cost-containment measures, will avoid using their economic leverage to maintain high quality standards on the theory that doing so would trigger tort liability.118
While judicial modification of the respondeat superior doctrine would be an
improvement over the de facto immunity some MCOs now enjoy under the
current version of the test, courts would be well-advised to look elsewhere for
mechanisms of MCO accountability. Several courts have done so, holding
MCOs accountable on the basis of ostensible agency and other related theories
of vicarious liability. It is to these doctrines that we now turn.
2. Ostensible Agency. Because it is easier to demonstrate an apparent
master/servant relationship than a real one, several courts have used the
doctrine of ostensible agency to hold MCOs vicariously liable for physician
malpractice.119 An ostensible agency relationship does not require actual
117. See Havighurst, supra note 68, at 587-89, 608-18.
118. See id. at 619 n. 80. The prediction that MCOs will distance themselves from medical decisions
to consumers’ detriment is illustrated by interest group activity in the political arena and in the courts.
Organized medicine has steadfastly resisted legislative proposals to hold MCOs exclusively liable for
physician malpractice on the ground that such proposals would give MCOs too great an incentive to
control physician decisionmaking. Interestingly, however, the American Medical Association and several other physician trade associations have established the American Medical Association/Specialty
Society Medical Litigation Project, a litigation resource center for which a prime objective is to persuade state courts to use vicarious liability doctrine to hold MCOs liable for the malpractice of independent physicians. At first blush, the Project’s work appears inconsistent with the AMAs opposition
to enterprise liability. Yet the two projects are, in fact, quite compatible. Because liability under respondeat superior and related doctrines turns on actual or apparent MCO control, organized medicine
may hope to shape liability rules in such a way that MCOs will be deterred from aggressively managing
care.
Using respondeat superior as the basis for evaluating MCO liability clearly serves the interests
of organized medicine. While officially “neutral” on the question of managed care, the AMA is committed to defending physician autonomy in medical decisionmaking as against intrusion by corporate
managers. Yet it is not at all clear that an MCO’s “hands off” policy is in consumers’ best interests,
especially once MCO payment mechanisms have created a financial conflict of interests between MCO
physicians and their patients.
119. See, e.g., Boyd v. Albert Einstein Med. Ctr., 547 A.2d 1229, 1235 (Pa. Super. 1988). The Boyd
court granted summary judgment for the defendant HMO on the issue of whether the treating physicians were its ostensible agents on the basis of the following factors: (1) the MCO “operate[d] on a direct service rather than an indemnity basis”; (2) the decedent paid physician fees to the HMO rather
than to the treating physician; (3) the decedent selected physicians from a list provided by the MCO
(the list included only those who had been screened by the MCO and had agreed to follow MCO
regulations); (4) MCO members could see a specialist only with their primary-care physician’s approval; and (5) when specialty care was approved, MCO members had no choice as to the identity of
the treating specialist. Id; see also McClellan v. Health Maintenance Org. of Pa., 604 A.2d 1053, 105658 (Pa. Super. Ct. 1992); Decker v. Saini, No. 88-361768 NH, 1991 WL 277590 (Mich. Cir. Ct. Oakland
County Sept. 17, 1991). Interestingly, the Decker court allowed a vicarious liability claim against an
MCO based upon the negligence of a nonparticipating specialist. But see Chase v. Independent Practice Ass’n, 583 N.E.2d 251, 255 (Mass. App. Ct. 1991) (rejecting plaintiff’s vicarious liability claim
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control; rather, liability is appropriate where the MCO has made express or
implied representations that independent contractor physicians are, in fact, its
servants, and a plaintiff has reasonably relied upon those representations.120 If
only because plaintiffs in ostensible agency cases enjoy a reduced burden of
proof, cases predicating MCO liability on ostensible agency tend to be more
doctrinally satisfying than those few cases that rely on respondeat superior to
hold MCOs liable. Like respondeat superior, however, ostensible agency is
ultimately an unsatisfactory test for determining whether an MCO should be
held vicariously liable for physician malpractice.
The two most likely ways in which an MCO might make an express representation that an independent physician is its employee are its inclusion of the
physician’s name in its directory of participating providers and its designation
of a primary care physician as coordinator of the care provided by the MCO if
the MCO uses a gatekeeper model. While these representations are significant,
they are probably insufficient to justify a finding of ostensible agency. First,
neither of these facts is inherently inconsistent with an actual independent contractor relationship between the MCO and the physician. As a result, the MCO
may be able to negate reasonable reliance on the plaintiff’s part by simply advising him of the true (that is, independent contractor) relationship between
the MCO and its physicians at the time of enrollment.121 Moreover, in most
communities, a single physician’s name is likely to appear in several different
provider directories.122 Where physicians in a given community are customarily
affiliated with multiple networks, it would be unreasonable to draw an inference of agency from such a listing.
Plaintiffs may be more successful where an MCO’s business structure
amounts to an implied representation of control. At one end of the spectrum
of possible business arrangements, a plaintiff might contract with an MCO and
be unaware of, or at least presumptively indifferent to, the identity of the pro-

against IPA because her MCO contract expressly stated the IPA was created to “arrange for” the provision of services to MCO members, not to provide those services itself); Raglin v. HMO Illinois, 595
N.E.2d 153, 157-58 (Ill. App. Ct. 1992) (finding no evidence that the plaintiff had relied on the MCO
for the quality of health care she received, that the MCO had exercised control over its physicians’
medical activities, or that it had held itself out as doing so).
120. See RESTATEMENT OF AGENCY, supra note 113, § 267 (“One who represents that another is
his servant or other agent and thereby causes a third person justifiably to rely upon the care or skill of
such apparent agent is subject to liability to the third person for harm caused by the lack of care or
skill of the one appearing to be a servant or agent as if he were such.”); RESTATEMENT (SECOND) OF
TORTS, supra note 38, § 429 (“One who employs an independent contractor to perform services for
another which are accepted in the reasonable belief that the services are being rendered by the employer or by his servants, is subject to liability for physical harm caused by the negligence of the contractor in supplying such services, to the same extent as though the employer were supplying them
himself or by his servants.”).
121. See Richard A. Hinden & Douglas L. Elden, Liability Issues for Managed Care Entities, 14
SETON HALL LEGIS. J. L. 1, 25 (1990); see infra text accompanying notes 138 through 140 (arguing that
reliance element is essential to the concept of ostensible agency). But see Havighurst, supra note 68, at
598 n. 31 (arguing that many courts ignore reliance requirement and collecting cases).
122. See Berenson, supra note 115, at 175.
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fessionals who will provide the services.123 Instead, the patient looks to the
MCO to provide or arrange for the provider of services of acceptable quality.
At the other end of the spectrum would be the traditional indemnity insurer.
In the latter case, although the insurer pays the bills, the patient is clearly not
relying on the insurer in connection with the quality of care he receives.124
Rather, the patient looks to the physician for medical services and the insurer
for payment. Most MCOs probably occupy a middle ground between these two
poles. The plausibility of a consumer’s claim that he was looking to the MCO
rather than to a negligent provider for services will depend on the degree to
which his choice of provider is restricted by the plan, the representations and
advertising of the plan regarding its role in providing high quality health care,
the controls the plan places on access to providers, and the degree of integration in the plan generally.125 The larger and looser the network of providers, the
harder the claim of reliance on the MCO rather than the provider will be to
sustain.
The main problem with the ostensible agency test is not that it never applies
to MCO-provider relationships, but rather that (like respondeat superior) its
fact-dependence needlessly increases the cost and uncertainty of the resulting
litigation. Significantly, if the ostensible agency test is to be the chief means of
holding MCOs legally accountable to consumers for quality problems, such accountability is likely to become increasingly illusory, even when MCOs are engaging in cost containment measures with foreseeable adverse consequences
for their patients. The reason the doctrine is likely to be ineffective against
MCOs over the long run is that it makes liability turn on whether the plaintiff
had reasonable grounds to misunderstand the nature of the MCO-provider relationship. As more courts use the ostensible agency doctrine to hold MCOs
vicariously liable for provider malpractice, MCOs can be expected to include
contractual language and other disclosures designed specifically to negate misunderstandings among plan members as to the independent contractor relationship between the plan and its physicians.126
Moreover, the doctrine cannot be coherently expanded to prevent MCOs
from employing such a strategy. Ostensible agency is an exception to the gen123. As when, for example, a patient is a member of a tightly integrated, staff-model HMO.
124. Cf. Mitts v. H.I.P., 478 N.Y.S.2d 910 (App. Div. 1984) (holding indemnity insurer not liable for
physician’s malpractice).
125. See Boyd v. Albert Einstein Med. Ctr., 547 A.2d 1229, 1235 (Pa. Super. Ct. 1988). But see Raglin v. HMO Illinois, 595 N.E.2d 153, 157-58 (Ill. App. Ct. 1992).
126. See CLARK C. HAVIGHURST, HEALTH CARE CHOICES 118-20 (1995); Richard A. Hinden &
Douglas L. Elden; Liability Issues for Managed Care Entities, 14 SETON HALL LEGIS. J., 25-26 (1990).
Generally, disclosure or disclaimers of agency relationships between the MCO and its providers may
or may not be effective depending on the jurisdiction’s emphasis on the actual reliance element. In
theory if not in practice, the degree of reliance depends on whether the court is applying an ostensible
agency theory, see RESTATEMENT (SECOND) OF TORTS, supra note 38, § 429, which merely requires
that services be accepted with the reasonable belief that the independent contractor is the defendant’s
agent, or an agency by estoppel theory, see RESTATEMENT OF AGENCY, supra note 113, § 267, which
requires actual, detrimental reliance. However, a disclaimer shielded an IPA from malpractice liability in Chase v. Independent Practice Ass’n, 583 N.E.2d. 251, 254 (Mass. App. Ct. 1991).

BREWBAKER.FMT4

Page 117: Spring 1997]

04/01/98 8:04 AM

IMPLIED WARRANTY OF QUALITY

147

eral rule that a principal is not liable for the torts of independent contractors.127
As noted above, the justification underlying the ostensible agency exception is
that the principal has either induced or wrongfully permitted a plaintiff to infer
the existence of a control relationship between itself and the independent contractor. The plaintiff’s justifiable reliance on the principal’s credit or reputation in engaging the independent contractors services provides a basis for altering the implicit prior conclusion that the relationship between the principal
and alleged agent is too attenuated to justify vicarious liability. Unfortunately
for injured plaintiffs, the doctrine’s conceptual structure leads inexorably to the
conclusion that the ostensible agent’s principal ought to be able to avoid liability by negating the plaintiffs reliance. Because the doctrine applies only between parties whose actual relationship, as a matter of law, cannot justify vicarious liability, the sole remaining basis for liability is the plaintiffs
misapprehension of that relationship.128 If the plaintiff cannot reasonably be
under a misapprehension of the principal’s relationship with its independent
contractor, the justification for departing from the general rule of nonliability
under respondeat superior is completely removed.
At least one court has strongly suggested its intention to resist any attempt
by health care providers to avoid vicarious liability by advising their members
that no actual agency relationship exists.129 Other courts may do so sub silentio
by denying summary judgment to MCOs where there is little factual basis for
crediting a plaintiffs claim of apparent agency. As a matter of policy and fairness, this sort of judicial conduct is understandable. The problem is the violence it does to ostensible agency as a legal doctrine. As argued above, ostensible agency principles cannot be expanded to apply in situations where there is
no reasonable appearance of a master-servant relationship. Indeed, a purported expansion would be a repudiation less of ostensible agency than of the
broader rule that immunizes principals from liability for the torts of their independent contractors. If courts, out of concern about policy and fairness, are
moving toward holding MCOs accountable for medical malpractice, an alternative legal doctrine will be required.
3. Nondelegable Duties. Of the vicarious liability rules, the most promising
exception to the general rule of MCO nonliability for independent physician
127. Ostensible agency “arises when a principal holds his agent out as possessing certain authority
or permits him to exercise or to represent himself as possessing such authority.” Nevada National
Bank v. Gold Star Meat Co., 514 P.2d 651, 653 (Nev. 1973). Furthermore, “[f]acts and circumstances
are sufficient to establish [ostensible agency] only when a person exercising ordinary prudence [and]
good faith … would be misled thereby . . . .” Lamb v. General Assocs., Inc., 374 P.2d 677 (Wash.
1962). Ostensible authority of an agent can be inferred only from the acts and conduct of the principal. See RESTATEMENT OF AGENCY, supra note 113, § 8.
128. Note that where an actual control relationship exists, a disclaimer is ineffective. See, e.g., Sanford v. Goodridge, 13 N.W.2d 40, 43 (Iowa 1944) (“It will not do for an employer to make a contract
which in many clauses loudly proclaims the independence of his contracting workman and in other
clauses circumvents this granted freedom by retaining in himself all the control that employers ordinarily possess over their employees.”).
129. See Grewe v. Mount Clemens Gen. Hosp., 273 N.W.2d 429, 435 (Mich. 1978).
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malpractice is the doctrine of so-called “nondelegable” duties. This doctrine
holds that “the employer’s enterprise, and his relation to the plaintiff [can be]
such as to impose upon him a duty which cannot be delegated to an
independent contractor.”130 The principals liability does not depend on a
finding of fault. Instead, he will be held liable for his contractor’s negligence
even if no master/servant relationship or other basis for vicarious liability (such
as ostensible agency) exists. No single defining characteristic exists that will
identify a duty as nondelegable, other than facts suggesting that “the
responsibility is so important to the community that the employer should not
be permitted to transfer it to [an independent contractor].”131 Some courts have
suggested that the doctrine applies to prevent businesses from delegating
functions to independent contractors for the express purpose of avoiding
responsibility for foreseeable personal injury.132
The nondelegable duty doctrine is less a rule of decision than a label courts
apply when considerations of policy or fairness dictate that it is inappropriate
to shield a principal from liability for an independent contractor’s torts.133 Because the nondelegable duty cases rest so strongly on policy, the rule could be
easily used as a remedy for the MCO’s unwarranted immunity without the conceptual difficulties associated with an expansion of ostensible agency doctrine.
Indeed, the main problems associated with MCO immunity would be solved134 if
courts began holding that MCOs that sell prepaid medical services (and not just
financing)135 owe a nondelegable duty to provide non-negligent care to their
customers.136
Despite the potential utility of the nondelegable duty rule in protecting
health care consumers, courts have been slow to apply it against corporate sellers of health care services. The primary reason cited by courts in rejecting the
doctrine is the traditional division of authority between doctors and hospitals.137
130. KEETON ET AL., supra note 26, § 71, at 511; see also RESTATEMENT OF AGENCY, supra note
113, § 214 (1958) (“A master or other principal who is under a duty to provide protection for or to
have care used to protect others or their property and who confides the performance of such duty to a
servant or other person is subject to liability to such others for harm caused to them by the failure of
such agent to perform the duty.”).
131. KEETON ET AL., supra note 26, § 71, at 512.
132. See, e.g., Hannola v. City of Lakewood, 426 N.E.2d 1187, 1190 (Ohio Ct. App. 1980) (“[P]ublic
policy requires that the hospital not be able to artificially screen itself from liability for malpractice in
the emergency room.”). For examples of circumstances in which the doctrine has been applied, see
KEETON ET AL., supra note 26, § 71 at 511-12.
133. See WILLIAM L. PROSSER ET AL., CASES AND MATERIALS ON TORTS 650 (9th ed. 1994) (“In
the last analysis, the cases represent ad hoc decisions that, as a matter of public policy, one cannot
avoid particular responsibilities by hiring someone else to discharge them, because of the importance
of the duty.”).
134. See supra Part III.A.
135. See infra Part IV.
136. See Brewbaker, Managed Care Liability, in MANAGED CARE, supra note 1, § 6.2.2 (arguing
that non-delegable duty theory is superior to ostensible agency as a basis for MCO liability);
Havighurst, supra note 68, at 614 (arguing that the non-delegable duty doctrine provides a sound basis
for MCO liability).
137. See Menzie v. Windham Community Mem’l Hosp., 774 F. Supp. 91, 95 (E.D. Conn. 1991)
(holding that the only duty of a hospital is to provide a place for treatment); Petratos v. Markakis, 637
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There may be other reasons for judicial reticence, however. In an era in which
many state courts appear concerned about the appearance of judicial activism,
the amorphous nature of the nondelegable duty rule may be a genuine obstacle
to its implementation. Perhaps more importantly, it is hard to characterize an
MCOs decision to use independent physicians rather than employees to deliver
medical services as a cynical attempt to delegate away liability for foreseeable
personal injury. Indeed, as Clark Havighurst has pointed out, MCOs that contract with independent physicians are adhering to the longstanding legal presumption that corporations should not employ physicians, but that physicians
should work only as independent contractors.138 This fact presents a formidable
obstacle to the argument that MCOs should be penalized if they delegate
judgments about medical decision-making to independent physicians.
IV
PUTTING THEORY INTO PRACTICE: APPLYING THE
IMPLIED WARRANTY THEORY
A. What is an MCO?
The preceding discussion of implied warranty theory has left an important
practical question unaddressed: Given the proliferation of business entities in
the health care industry, which ones should be subject to the implied warranty?
This article argues that all MCOs (defined as firms that are in the business of
selling or arranging for the sale of medical services)139 should be subject to the
warranty. Under this proposed definition, a traditional indemnity insurance
company would not be considered an MCO, and thus would not be liable for
physician malpractice, because it provides only financial, not medical, services.
The policyholder is free to select treatment from any licensed health care provider of the services covered under the policy, and the insurer’s review of medical decision-making is limited to determining whether the contract provides
coverage. The insurer neither sells nor arranges for the sale of the medical
services its insured will receive; it only commits to reimburse the insured for

N.E.2d 13, 15 (Ohio Ct. App. 1993) (hospital has duty to grant staff privileges to competent physicians;
therefore it is the duty of the physician to practice medicine non-negligently); Kelly v. St. Luke’s
Hosp., 826 S.W.2d 391, 395 (Mo. Ct. App. 1992) (rejecting idea that providing emergency room services is an inherently dangerous activity). One court concluded that decisions applying the nondelegable duty represent “misdirected attempts to circumvent the necessity of proving” liability based
upon established agency principles. Albain v. Flower Hosp., 553 N.E.2d 1038, 1047 (Ohio 1990), overruled by Clark v. Southview Hosp. & Family Health Ctr., 628 N.E. 2d 46 (Ohio 1994). Additionally,
the Albain court held that “[t]he practice of medicine in a hospital by an independent physician with
staff privileges does not involve the type of risks and precautions required as contemplated by the
‘non-delegable duty’ exception.” Id. at 1048.
138. See Havighurst, supra note 68, at 632-33.
139. Although this definition resembles a definition found in the Model HMO act, cf. NAIC
MODEL LAWS, REGULATIONS AND GUIDELINES, MODEL HMO ACT §2(M) (1991), it is not intended
to be limited to HMOs, as discussed below.
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expenditures related to covered services at the rate provided for in the policy.
In stark contrast are tightly integrated sellers of medical services such as the
staff model HMO, perhaps the clearest example of an entity meeting the MCO
definition. Staff-model HMOs sell the services of their physician-employees
and associated professionals and institutions on a prepaid basis. Members may
receive care only from an HMO employee; the services of other physicians are
not covered. The HMO both provides and finances its members’ care. Like an
insurance policy, HMOs protect their members from financial disaster in the
event they need extensive medical care; member premiums create a pool of
funds from which the cost of care can be satisfied. However, care is not provided through independent providers of the consumer’s choice but is actually
delivered by the HMO acting through affliliated institutions and professionals.140
Why should these two types of firms—the indemnity insurer and the
HMO—be distinguished for liability purposes? The best way to answer this
question is to understand the mechanisms by which MCOs have been able to
undercut traditional health plans and gain market share. While some have argued that MCO success has been due primarily to adverse selection,141 the fact
that MCOs actually sell medical services gives them important competitive advantages.
Consumers with traditional indemnity insurance purchase medical services
directly from providers. The fact that they are insured reduces their incentive
to control expenses. Even unusually cost-conscious patients are unlikely to be
effective negotiators because they have little economic leverage, and information about the cost and quality of alternatives in the marketplace will be available only at great expense. In contrast, MCOs can use the purchasing power of
a large group of consumers to extract price concessions. Physicians and other
providers that wish to compete for MCO members as patients must accept discounted reimbursement rates or risk being foreclosed from the MCOs’ patient
population.142 Also, MCOs can spread the cost of acquiring information over a
larger pool of subscribers. Not surprisingly, MCOs can and do fare better than
individual consumers in negotiations with providers.143
Once an MCO has assumed the position of “middleman” between consumer and provider, it cannot avoid influencing the quality of services it provides. This reasoning suggests that entities occupying a middle ground between
tightly integrated HMOs and traditional indemnity insurance—for example,
preferred provider organizations (“PPOs”) and managed care plans offering a
140. See generally Michele M. Garvin, Health Maintenance Organizations, in MANAGED CARE, supra note 1, at 1-1 to 1-239 (describing HMOs).
141. See Joseph P. Newhouse, Is Competition the Answer?, 1 J. HEALTH ECON. 109 (1982); Gail R.
Wilensky & Louis F. Rossiter, Patient Self-Selection in HMOs, 5 HEALTH AFF., 66 (Spring 1986).
142. See Charles D. Weller, “Free Choice” as a Restraint of Trade in Health Care Delivery, 69 IOWA
L. REV. 1355-59 (1984) (distinguishing between “guild free choice” and “market free choice”).
143. See Harold S. Luft, Perspective and Evidence on Efficiency in Managed Care Organizations, in
COMPETITIVE MANAGED CARE: THE EMERGING HEALTH CARE SYSTEM 30, 35-36 (John D. Wilkerson et al. eds. 1997).
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point of service option—should also be deemed to warrant the quality of their
services. From a purely formalistic vantage point, PPOs and similar entities are
not as clearly sellers of medical services as are HMO. PPO members are
merely given financial incentives to patronize preferred providers, but they are
free to buy medical services from the provider of their choice. Reimbursement
is available (albeit at a reduced rate) even if an unaffiliated provider is selected.144
However, the argument that PPOs should not be considered sellers of
medical services is not finally persuasive. Presumably, providers accept a
PPOs reduced fee schedule and other terms only because they perceive that
they will be better off doing so.145 That is, they perceive that the PPO business
strategy—using financial incentives to induce patients to use selected providers,
marketing lists of preferred providers, etc—is likely to generate more patients
despite the PPO members option to patronize unaffiliated providers. The PPO
and its providers assume that the PPO incentives will “lock-in” a sufficiently
large number of patients to make provider affiliation worthwhile.
If this is the case, PPOs and similar entities occupy substantially the same
position as more integrated MCOs with respect to their ability to influence the
quality of the medical services they sell. Their decisions as to network membership, treatment setting, and payment mechanism, will shape the quality of
care their members receive. In addition, whether or not they choose to do so,
they have the capacity to manage their members’ care to assure quality. These
rationales for implying a warranty of quality apply with equal force to PPOs
and to more integrated MCOs.
Despite the similarities between PPOs and more tightly integrated plans,
the prospect that a PPO will pay for services rendered by an independent provider raises the additional question of whether the implied warranty of quality
should cover out-of-plan services. At an intuitive level, the answer would seem
to be no. Consumers choosing care from nonparticipating providers do not rely
on the plan’s judgment in selecting the provider; moreover, the plan has no
means of affecting the provider’s treatment of the plan member and therefore
no mechanism with which to protect itself against liability. On the other hand,
relieving the MCO of responsibility for nonparticipating providers would create some incentive for plans to exclude from their networks providers specializing in the treatment of high-malpractice-risk diseases.146 In the case of inte144. See generally James C. Dechene, Preferred Provider Organizations, in MANAGED CARE , supra note 1, at 2-1 to 2-154 (describing PPOs).
145. But see Berenson, supra note 115, at 175-76 (noting physician reluctance to drop MCO contracts because of loyalty to patients).
146. See Schleier v. Kaiser Foundation Health Plan, 876 F.2d 174, 178 (D.C. Cir. 1989) (“It might
be said that because Kaiser had eliminated cardiology from its coverage, the actions of Sherber, a cardiologist, do not fall within Kaiser’s regular business offerings, but we think such an argument circumvents the intention of this final factor— to shield an employer from liability for the actions of an employee who was acting outisde his field of expertise (for example, a doctor who negligently fixes a
car)—and so we consider Sherbers actions to fall within the scope of Kaisers regular business.”); see
also Decker v. Saini, No. 88-361768 NH, 1991 WL 277590 (Mich. Cir. Ct., Oakland County Sept. 17,
1991). The Decker case included a vicarious liability claim against an HMO based on the negligence of
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grated managed care plans offering a point-of-service option, primary care
gatekeepers might even be encouraged to refer particularly high-risk patients
to out-of-plan providers to escape liability.
On balance, the better rule is not to imply a warranty of quality with respect
to out-of-plan providers to which the patient has self-referred.147 Where out-ofplan treatment is the result of a referral by a participating physician, there is
good reason to hold the MCO liable notwithstanding the lack of a continuing
relationship with the out-of-plan provider: The referring physician can and
should be encouraged to exercise some degree of control over the member’s
care by making a careful referral. A rule that made MCOs liable for the malpractice of nonparticipating physicians even when patients self-referred might
create strong incentives for health plans to eliminate all coverage for selfreferred services. Because PPOs and point-of-service plans are quite popular
among consumers, courts should be wary of inadvertently foreclosing the selfreferral option. In addition, some of the concerns about network design may
be alleviated by marketplace forces, accreditation requirements, and regulation.
A final issue concerns the apportionment of liability among multiple MCOs
in a single chain of distribution. It is not uncommon for HMOs and other payors to contract with physician-hospital organizations, individual practice associations (IPAs), PPOs, and other MCOs in order to establish a network sufficient to serve their patients. Assuming all the entities in the chain are sellers of
medical services, which of them should be liable for a judgment? The best answer is probably all of them.148 By definition, each of the entities in the distribution chain is in a contractual relationship. Given this fact and the remarkable
variety of health plan structures, courts would be far wiser to hold all sellers of
defective services jointly and severally liable, leaving the parties free to negotiate their own indemnity and contribution arrangements as part of their agreements with each other. Not only would this conclusion protect injured consumers by helping to assure them of compensation, the parties are in a far better
position than the courts to determine who is best situated to bear liability risks.
In addition, the other entities in the chain would have a strong interest in assuring that the parties they contracted with were financially solvent and could
meet their obligations in the event of a large judgment.149

a nonparticipating specialist. Although the complaint suggested that a participating physician had misrepresented the specialist’s status, the court noted that “it would be against public policy to allow
HMOs, as a matter of law, to escape liability for their members’ treatment by simply referring them
outside the HMO plan.” Id. at *4. See also Sage et al., supra note 72, at 24 (“[I]f health plans are
spared the cost of malpractice caused by unaffiliated practitioners, they will be less likely to minimize
out-of-network utilization by affiliating with the highest quality physicians and to develop systems that
provide easy access to emergency services.”).
147. Cf. Sage et al., supra note 72, at 24 (arguing that MCOs and out-of-network practitioners
should share liability).
148. Cf. RESTATEMENT (THIRD) OF TORTS, supra note 14, §1 cmt. e.
149. See RICHARD A. POSNER, ECONOMIC ANALYSIS OF LAW 188 (4th ed. 1992); WILLIAM M.
LANDES & RICHARD A.POSNER, THE ECONOMIC STRUCTURE OF TORT LAW 205-09 (1987).
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B. Implied Warranty Theory and the Courts
Although courts have yet to employ an implied warranty of quality theory
in a malpractice case involving an MCO, many of the reported decisions that
impose liability on MCOs are better understood in light of implied warranties
than under the doctrines they purport to apply. In Schleier v. Kaiser Founda150
tion Health Plan of the Mid-Atlantic States, for example, the U.S. Court of
Appeals for the D.C. Circuit found that an independent consulting physician
was an actual servant of a Kaiser HMO. Shedd Smith had been hospitalized by
his Kaiser physician after suffering severe chest pain. The Kaiser physician
asked Dr. Sherber, “a cardiologist who was an outside consultant and not a
Kaiser physician,”151 to examine Mr. Smith. After some additional testing, Dr.
Sherber determined that Smith probably did not have coronary disease and
therefore did not restrict his activities. Some six weeks later, Mr. Smith died,
apparently of coronary artery disease, after mowing his lawn. Smiths personal
representative sued Kaiser on account of the failure to diagnose and treat
Smiths coronary artery disease.
Applying the District of Columbia’s test,152 the court found that a masterservant relationship existed between Kaiser and Dr. Sherber. According to the
court, “the most important factor”153—Kaisers power to control Sherber—was
met “in that [Sherber] answered to Smiths primary care-taker, a Kaiser doctor.”154 This conclusion is perhaps defensible on the ground that the respondeat
superior inquiry asks whether the principal has the right to supervise the agent,
not whether it actually did so.155 On the other hand, the opinion does not explain in what respects Dr. Sherber might have been answerable to the unnamed
Kaiser physician. Presumably, the reason Dr. Sherber had to be called in was
because the Kaiser physician considered himself incompetent to treat Smith
adequately. Thus, it seems unlikely that the Kaiser physician was reviewing Dr.
Sherber’s medical judgment. Nor is there any evidence that Sherber’s judgment was controlled directly or indirectly through his relationship with Kaiser.
Viewed in light of the implied warranty theory, however, the case makes
perfect sense. Kaiser is a highly-integrated health maintenance organization
known for its aggressive and effective management of the cost and quality of
the care its patients receive. The Kaiser physician, not the patient, selected Dr.
Sherber, and Kaiser paid him, at least in part because Kaiser had no suitable
specialist on staff. Kaiser owed the plaintiff a duty to stand behind the services
it sold.
A similar case, Dunn v. Praiss,156 involved a consulting physician’s failure to
150.
151.
152.
153.
154.
155.
156.
1995).

876 F.2d 174 (D.C. Cir. 1989).
Id. at 176.
See id. at 177 (quoting LeGrand v. Insurance Co. Of N. Am., 241 A.2d 734, 735 (D.C. 1968)).
Id.
Id.
RESTATEMENT OF AGENCY, supra note 113, § 220.
606 A.2d 862 (N.J. Super. Ct. App. Div. 1992), rev’d on other grounds, 656 A.2d 413 (N.J.
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diagnose testicular cancer. As in Schleier, the tortfeasor was not an employee
of the decedent’s HMO. Instead, he was a urologist employed by an independent medical group that had contracted to provide urological services to the
HMO’s members on a nonexclusive basis. According to the court, the following facts were sufficient to establish an actual master/servant relationship between the HMO and the urologist: (1) the group was paid on a capitated basis;
(2) they were not free to accept or reject individual HMO patients; (3) additional referrals to the group were at the HMO’s option; and (4) the urologist
examined the decedent on the HMO’s premises.157
A strong argument can be made that the Dunn court erred in finding liability on the basis of respondeat superior. While the argument is frequently made
that capitation should give rise to an inference of vicarious liability,158 capitation
is, in essence, a fixed-price contract between the MCO and its physician.159
Such contracts usually indicate an independent contractor relationship because
they require the party rendering services to assume business risks, something
employees rarely do.160 Moreover, capitation seems likely to reduce an MCOs
incentives to supervise contracting physicians, since the MCO no longer bears
the risk that the provider will overutilize services.
The second and third factors cited by the Dunn court likewise say nothing
about the control the HMO would exert over the medical group’s treatment,
but arguably relate only to the volume of business the group had undertaken to
perform. The fourth factor (examination on HMO premises) would constitute
some evidence of a master/servant relationship in that the HMO provided the
place of work and possibly the “tools and instrumentalities” used by the consultant.161 Indeed, this fact might lend strong support to a finding of ostensible
agency. Nevertheless, evidence for the actual master/servant relationship
found in Dunn seems slender.
Again, however, the case is easily understandable under an implied warranty theory. Although the defendant radiologists were not HMO employees,
the HMO selected them and sold their services to the plaintiff. Although the
factors cited by the court are of marginal relevance to the issue of control, they
are extremely relevant to the question of corporate responsibility. The defendant HMO established a payment system it knew created incentives to limit
care. It had selected and maintained an ongoing relationship with the radiology
group—selling the group’s services to the plaintiff on HMO premises as part of
157. See id. at 868.
158. See, e.g. William A. Chittenden, III, Malpractice Liability and Managed Health Care: History
and Prognosis, 26 TORT & INS. L.J. 451, 457 (1991).
159. But see id. at 457 (capitation is “analogous to an employee salary system insofar as the physician’s compensation remains the same regardless of the nature or complexity of the medical services
rendered.”) This statement is true only with respect to gross revenues. The better comparison is between a salary and the provider’s net revenues.
160. Cf. LANDES & POSNER, supra note 149, at 207 (“[T]he independent contractor by definition
does not work under the employer’s … direction but rather promises a certain output in exchange for
the contract price.”).
161. RESTATEMENT OF AGENCY, supra note 113, § 220.
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a total package of medical care.
Similar observations can be made about the cases holding MCOs liable on
the basis of ostensible agency. In the leading case of Boyd v. Albert Einstein
162
Medical Center, a Pennsylvania appellate court reversed a summary judgment
in favor of an IPA-model HMO on the vicarious liability issue. Despite the fact
that the alleged malpractice was committed by independent physicians, the
court found that the facts would support a conclusion that the physicians were
the defendant HMO’s ostensible agents. Specifically, (1) the HMO “operate[d]
on a direct service rather than an indemnity basis,” (2) the decedent paid physician fees to the HMO rather than to the treating physician, (3) the decedent
selected her physicians from a list provided by the HMO that included only
those who had been screened by the HMO and had agreed to follow its regulations, (4) HMO members could see a specialist only with their primary physician’s approval, and (5) when specialty care was approved, HMO members
could not choose their treating specialist.163
The result in Boyd is more defensible from a doctrinal perspective than
those in Schleier and Dunn, if only because the conclusion that an ostensible
agency relationship exists is based on a reasonable plaintiff’s perceptions rather
than on the realities of the MCO-physician relationship. As noted above, the
fact that the plaintiff bought prepaid services from an organization that also restricted the patients choice as to who would deliver the services adds credibility
to the argument that the plaintiff was looking to the plan rather than the provider for medical services. Thus the “direct service” nature of the plan in Boyd,
the limitations on plan members’ choice of physician, and, particularly, the fact
that plan members had no choice at all as to specialist care provide support for
the court’s conclusion. On the other hand, there is little indication in the opinion that the plan represented the independent physicians as its servants or that
the plaintiff actually relied on their identification with the plan in seeking
treatment. As argued above, it seems doubtful that a listing in a directory of
participating providers should amount to the plan’s holding out the listed physicians as its agents, especially in a community where providers regularly join
multiple networks. In addition, the Boyd court relied extensively on language
in the HMO contract that the injured party may never have read.164
The Boyd case is likewise better understood as implying a warranty of
quality. Members of the Boyd HMO could see a specialist only with their primary care physician’s approval, and, when specialist treatment was approved,
the patient was not permitted to choose the specialist.165 The HMO was deliberately structured so that HMO members would see nonspecialists whenever possible. The policy of discouraging self-referral to specialists is certainly defensible; patients often seek out an expensive specialist when the same care could be
162.
163.
164.
165.

547 A.2d 1229 (Pa. Super. Ct. 1988).
Id. at 1235.
See id. at 1232-34.
See id. at 1235.
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provided much more cost-effectively through a primary care physician. On the
other hand, primary care physicians are by definition generalists. Undoubtedly,
some patients suffer because of limitations on access to specialists. Where an
MCO puts structures into place that will foreseeably harm certain patients
(even where those structures might be justifiable from a policy perspective), it
is no surprise that courts are unwilling to shield them from accountability entirely.
V
CONCLUSION
The accountability of MCOs has emerged as a crucial issue in connection
with the development of a market-based health care system. The implied warranty of quality proposed in this article would represent a significant step in fulfilling the legal system’s obligation to ensure that consumers get what they bargain for when they deal with health plans. Although implying a warranty on
the part of MCOs is a new idea, it is far from revolutionary. To the contrary,
the law’s current reluctance to require MCOs to stand behind the services they
sell is far more striking than would be the relatively modest extension of existing law called for in this article.
I have proposed the implied warranty of quality as a mechanism for dealing
with an important, yet relatively narrow, problem: MCOs’ liability for the negligent acts and omissions of affiliated providers. Adoption of the implied warranty would produce a number of important beneficial effects—including generating increased quality, efficiency and accountability in the health care
system.
The implied warranty theory is also likely to be useful in slowing some of
the more destructive trends in managed care liability litigation. In the absence
of a straightforward basis for holding MCOs accountable for medical decisions,
plaintiffs have attempted to characterize MCO payment mechanisms as inherently wrongful such that their mere use constitutes negligence or even fraud.166
Judges and juries, however, are ill-equipped to decide whether such arrangements are reasonable, in large part because legal proceedings focus on the arrangements’ effects in the single case before the jury.167 In that narrow context,
financial incentives that seem entirely defensible in a broader policy framework
are easily exploited to paint a picture of a deep-pocketed corporate villain.168 If
166. See, e.g., Pulvers v. Kaiser Foundation Health Plan, 160 Cal. Rptr. 392 (Ct. App. 1979) (ruling
that HMO incentive plan does not constitute fraud or breach of warranty because, in the absence of
negligent treatment, such plans are consistent with public policy and are not intended to interfere with
sound medical judgment); Bush v. Dake, No. 86-25767-NM (Mich. Cir. Ct. Apr. 27, 1989), described
in 1 FURROW ET AL., supra note 22, § 8.2c (jury question existed as to whether HMO payment mechanism was proximate cause of physicians negligent failure to order test); Gross v. Prudential Health
Care Plan, No-CJ-9474267 (Okla. City Ct. Oct. 1, 1996), reported in 25 H EALTH LAW DIGEST, 55 n.1
(1997).
167. It has been argued that evidence of the benefits of such arrangements is even inadmissible on
the theory that it invites jurors to consider their own financial interests in deciding the case.
168. See Berenson, supra note 115, at 177-78; Mark A. Hall, Rationing Health Care at the Bedside,
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such claims prove successful, the risk of large damage awards may force MCOs
to discontinue cost-containment mechanisms that appear to have proven effective in controlling health care costs.
Instead of trying to evaluate either the morality or the wisdom of MCO
payment mechanisms, courts should focus on the quality of care patients receive. Because MCOs cannot avoid influencing the quality of care their physicians provide, they should be held responsible when the care they provide does
not conform to the malpractice standard. By holding MCOs to an implied warranty of quality, courts can and should short-circuit inquiries into the desirability of contractual arrangements between MCOs and their providers, leaving
regulation of managed-care techniques to the market and the political branches
of government.169
In the space of only a decade or so, the U.S. health care system has been
radically transformed. It is no surprise that changes of such magnitude within a
relatively short period of time have put stresses on legal frameworks that were
established when medicine was practiced the old-fashioned way—by independent practitioners without outside “interference” from hospitals, insurers, and
the like. Changes in the health care system demand new forms of accountability. The implied warranty of quality presents an opportunity for courts to adjust to the new realities of health care delivery by drawing on their experience
in other settings in which consumers put their safety at risk in the course of
transactions with commercial enterprises.

69 N.Y.U.L. REV. 693 (1994).
169. Indeed, ERISA might usefully preempt such claims which, unlike most utilization review decisions, exert significant constraints on health plan administration.

